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Abstract

FOCAL ADHESION KINASE, A MAJOR REGULATOR OF
OLIGODENDROCYTE MORPHOLOGICAL MATURATION AND MYELINATION
By Audrey D. Lafrenaye
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: Babette Fuss, Ph.D., Associate Professor, Department of
Anatomy and Neurobiology
The formation of the myelin sheath is a crucial step during development
because it enables fast and efficient propagation of signals within the limited
space of the mammalian central nervous system. During the process of
myelination, oligodendrocytes actively interact with the extracellular matrix
(ECM). These interactions are considered crucial for proper and timely
completion of the myelin sheath. However, the exact regulatory circuits involved
in the signaling events that occur between the ECM and oligodendrocytes are
currently not fully understood. Therefore, in this dissertation we investigated the
role of a known integrator of cell-ECM signaling, namely, focal adhesion kinase
(FAK), during oligodendrocyte morphological maturation in vivo and in vitro.
Conditional and inducible FAK-knockout mice (Fakflox/flox: PLP/CreERT
mice) were generated to observe the effect of FAK loss on myelination in vivo.
The role of FAK during post-migratory premyelinating oligodendrocyte
morphological maturation was explored in vitro using primary rat oligodendrocyte
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cultures in combination with siRNA or inhibitor treatment.
When inducing FAK knockout just prior to and during active myelination in
vivo, we observed a significant reduction in the number of myelinated fibers
following initial myelination. In addition, our data revealed a decreased number
of primary processes extending from oligodendrocyte cell bodies at this stage of
development under induction of FAK knockout. In contrast, myelination appeared
normal on postnatal day 28.
Our in vitro data demonstrated that reduction of FAK expression or activity
affected the oligodendrocyte process network maturation in a way that is unique
to the ECM substrate present. More specifically, our data suggest that FAK
restrains the expansion of the oligodendrocyte process network in the presence
of fibronectin and promotes expansion of the oligodendrocyte process network in
the presence of laminin-2. We showed that the FAK-mediated restriction of
oligodendrocyte morphological maturation is tightly developmentally regulated;
being highly active during early stages of post-migratory premyelinating
oligodendrocyte morphological maturation but greatly diminished at the later
stages of oligodendrocyte development. Thus, our data suggest that FAK
controls the efficiency and timing of CNS myelination during its initial stages, at
least in part, by regulating oligodendrocyte process network morphological
maturation.

Chapter 1
An introduction to oligodendrocyte biology and focal adhesion kinase

The oligodendrocyte is the myelin producing cell of the central nervous
system (CNS), responsible for proper conduction of axonal signals. In certain
diseases these cells and the myelin that they produce is targeted leading to a
wide range of dysfunctions. Although there are oligodendrocyte progenitor cells
(OPCs) found within areas of myelin damage there is limited, if any,
remyelination (Nait-Oumesmar et al. 1999, Chang et al. 2002). The process of
initial myelination during normal CNS development is not well understood;
therefore identifying potential key regulators of normal CNS myelination could
lead to promising therapeutic targets in disease states. The following
dissertation research focuses on elucidating the role of focal adhesion kinase
(FAK), a known integrator of cell-ECM signaling and regulator of cytoskeletal
remodeling, during oligodendrocyte morphological maturation and myelination.

Why we need myelin
The primary function of an oligodendrocyte in the CNS is to produce a
uniquely lipid-rich myelin sheath that enwraps the axon. Myelin is one of two
evolutionary mechanisms utilized in the nervous system to expedite axonal signal
transduction over great distances. The first of these mechanisms is the
enhancement of axonal diameter in proportion to the distance signals travel,
however, if this were the only mechanism utilized the human spinal cord would
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be the width of a tree trunk to accommodate the diameter of all the axons
traveling to our extremities. The second evolutionary mechanism is the addition
of the myelin sheath to invest the axons at specific intervals, allowing the speed
of conduction to increase exponentially without a concomitant increase in the
diameter of the axon (Sanders & Whitteridge 1946). In saltatory conduction
myelin functions to drastically increase the resistance to outward current flow,
limiting the area of ion exchange to small unmyelinated sections throughout the
length of the axon, drastically reducing the energy required to propagate the
signal (Kettenmann 2005, Lazzarini 2004).
The myelin sheath functions as it does due to both its high-lipid
composition and the domains that it forms in association with the axonal surface
(Uzman & Rumley 1958, Simons & Trajkovic 2006). The domains formed by the
myelin sheath are: the node of Ranvier, the internode, the paranode, and the
juxtaparanode.
The node of Ranvier is the myelin-free zone of the axonal surface in which
ion exchange is allowed, producing electrical current. This area only constitutes
0.1-0.3% of the total axonal surface and is characterized by high sodium channel
concentration, allowing for ion exchange and subsequent membrane
depolarization (Salzer et al. 2008, Rosenbluth 2009). The formation of the node
is well characterized in the peripheral nervous system, however remains largely
unclear in the CNS. Clustering of the sodium channels on the axonal surface in
the CNS does, however, appear to be regulated by contact with mature
oligodendrocytes (Kaplan et al. 1997, Kaplan et al. 2001, Dupree et al. 2005).
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The large area in which the myelin membrane is in direct apposition to the
axonal surface is the internode (Salzer et al. 2008). The wraps of myelin at the
internode compact with myelin maturation; squeezing the cytoplasm from
between the cellular membranes forming distinct regions, an electron dense
major dense line and a space between the two extracellular-facing myelin
membranes called the intraperiod line (De Robertis et al. 1958, Kettenmann
2005). The axon diameter regulates whether it requires myelination (Camara et
al. 2009, Matthews & Duncan 1971). The number of myelin wraps of the
internode around the axon is also determined by the diameter of the axon being
myelinated (Hildebrand & Waxman 1984, Fraher et al.1988, Schwab & Schnell
1989)
The areas adjacent to the node of Ranvier were once thought to be one
structure called the paranode, however, two domains with very different
molecular characteristics have now been identified: the paranode and the
juxtaparanode (Kettenmann 2005). The paranode is the region in which the
lamella of the myelin sheath terminate on the axonal surface in cytoplasmic-filled
arms called paranodal loops. The paranodal loops are uniquely associated with
the axonal surface through association of axonal contactin with myelin
membrane surface neurofasin 155 forming paranode specific adhesions called
transverse bands, which are stabilized by spectrins (Salzer et al. 2008, Simons &
Trajkovic 2006).
The second domain, the juxtaparanode, is more proximal to the internode
than the paranode. The axonal surface of the juxtaparanode expresses
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potassium channels as well as unique adhesion molecules that associate with
the myelin membrane (Salzer et al. 2008). The function of the potassium
channels within this region is still poorly understood, however, it is hypothesized
that the placement of the potassium channels underneath the myelin sheath
reduces the amount of energy required to repolarize the neuronal membrane
following an action potential and prevents after potentials (Rosenbluth 2009).
Active myelination occurs in four distinct phases 1) axonal recognition, 2)
synthesis of myelin components, 3) axonal wrapping, and 4) myelin compaction
(Simons & Trajkovic 2006). While the domains of myelin in the CNS are well
characterized the process of myelin formation by the oligodendrocyte is still
largely unknown. Studies have implicated axonal electrical capability and signals
sent from the axonal surface in enhancing the initiation of oligodendrocyte
myelination, however, these mechanisms are still poorly understood (Ishibashi et
al. 2006, Spiegel & Peles 2006, Simons & Trajkovic 2006).

Multiple Sclerosis (the reason for the research)
The requirement of the myelin sheath for normal nervous system function
is evident in diseases in which myelin is disrupted. There are two main types of
myelin injury, those that disrupt myelin as a result of another insult (secondary
myelin diseases) and those injuries that directly affect myelin and
oligodendrocytes in the CNS (primary myelin diseases) (Kettenmann 2005,
Lazzarini 2004). The primary myelin disorders are further subdivided into those
that disrupt the proper formation of the myelin sheath (dysmyelinating diseases),
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such as in the case of leukodystrophies, and diseases which destroy properly
formed myelin (demyelinating diseases) (Lazzarini 2004).
Multiple sclerosis (MS), the major primary demyelinating disease of the
CNS, affects approximately 400,000 people in the United States, with
approximately 200 new cases daily (Multiple Sclerosis Society 2010). The cause
of MS remains largely unknown; however, various environmental and genetic
factors have been linked to increased prevalence. MS is usually diagnosed in
young adults between the ages of 20 to 50 years old and is more common in
females; being more than twice as prevalent as in males (Multiple Sclerosis
Society 2010). The signs and symptoms of MS vary widely based on the stage
of the disease and the area of the CNS most affected.
There are four main types of MS: preclinical, relapsing-remitting,
secondary progressive and primary progressive (Fox et al. 2006b). The
preclinical stage is characterized as the time prior to onset of symptoms. The
majority (85%) of patients diagnosed with MS are in the relapsing-remitting stage
of the disease, which is characterized by relapsing symptoms that resolve over
time. Of people diagnosed with relapsing-remitting MS half will develop the
secondary-progressive stage of the disease within ten years; in which remissions
become infrequent and neurological symptoms progressively worsen (Multiple
Sclerosis Society 2010). Approximately 15% of MS patients initially present with
a form of MS in which there are no remissions and the neurological symptoms
continuously worsen: primary progressive MS (Fox et al. 2006b).
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There are three main issues to address in MS: the auto-immunological
aspect, the loss of myelin and oligodendrocytes, and the axonal damage.
Current therapeutic strategies to combat MS are focused on modulating the
immune system (Fox et al. 2006b), which has been well characterized in MS.
Neuronal damage could be precipitated by the immune response or following the
loss of myelin and oligodendrocyte support, however this is still a point of debate
within the field (McFarland & Martin 2007, Halfpenny et al. 2002, Geurts &
Barkhof 2008, Collin et al. 2007). There are also changes in extracellular matrix
(ECM) composition within MS lesions which could be associated with the
pathological symptoms (Sobel & Mitchell 1989, Comabella & Martin 2007, Satoh
et al. 2009, Cossins et al. 1997, Sobel 1998, van Horssen et al. 2007).
While the immune response is well characterized in MS there is still much
that is not well understood regarding oligodendrocyte myelination and there are
currently no therapies to enhance remyelination. Premyelinating
oligodendrocytes are found in the MS lesion, however, they do not properly
develop and there is limited remyelination (Chang et al. 2002, Kuhlmann et al.
2008). Due to the inherent limited capacity for remyelination within MS lesions
and the lack of knowledge regarding molecular players required for initial myelin
formation, the examination of molecules, such as focal adhesion kinase (FAK),
known to regulate morphological remodeling in various cell types could bring us
one step closer to enhancing remyelination in multiple sclerosis lesions.
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Oligodendrocyte development
To elucidate potential factors that would promote remyelination in disease
states we first need to better understand the normal developmental progression
of oligodendrocyte differentiation and myelination. Oligodendrocytes in
dissociated cell culture develop remarkably similar to in vivo conditions where in
it has been easier to study their biochemical properties during development
(Abney et al. 1981, Miller 1996).
The specification of oligodendrocytes throughout the CNS most likely
occurs in waves throughout the later aspect of the third trimester in humans or
early postnataly in the rodent (Kessaris et al. 2006). Specification of
oligodendrocytes has been most well characterized in caudal regions of the CNS,
namely the spinal cord, and is understood to occur similarly within the various
regions of the CNS. Oligodendrocytes begin as a constituent of the
neuroepithelium in the ventral neural tube under the induction of sonic hedgehog
(Shh) (de Castro & Bribian 2005, Nery et al. 2001, Wegner 2008). A small
percentage of oligodendrocytes also arise from the dorsal aspect of the neural
tube, however the signaling involved in their specification is not well understood,
accordingly in this section we will focus on the ventrally derived oligodendrocytes
(Miller 2002, Richardson et al. 2006). Shh induces the production of the basic
helix-loop-helix transcription factors olig1 and olig2 (Nery et al. 2001, Nicolay et
al. 2007).
Motor neurons expressing olig2 also arise from roughly the same area of
the neural tube prior to glial specification under the control of shh leading to
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some debate as to what constitutes an early glial progenitor (Jakovcevski &
Zecevic 2005, Miller 2002, Masahira et al. 2006, Nicolay et al. 2007, Wegner
2008).
In OPCs the transcription factor olig2 is thought to induce the expression
of the transcription factor sox10 as well as the platelet-derived growth factor α
receptor (PDGFαR) (Figure 1.1 A) (Wegner 2008, Zhou et al. 2000). Olig2 also
plays a role in the expression of Nkx2.2, which has been surrounded by some
controversy due to the differences in timing of Nkx2.2 expression. The
expression of olig2 in association with sox10 and Nkx2.2 has been shown to be
required for oligodendrocyte fate specification in both the chick and mouse (Liu et
al. 2007).
OPCs have a specific membrane constituent including the A2B5 antigen
and PDGFαR, the ligand for which is expressed by both astrocytes and neurons
and functions to promote OPC proliferation (Miller 1996, Schnitzer & Schachner
1982, Timsit et al. 1995, Sim et al. 2006, Simons & Trajkovic 2006). These
progenitors migrate vast distances from their periventricular origin to their site of
action. Once OPCs reach their final destinations their migratory capabilities drop
drastically and they differentiate into O4 antigen expressing post-migratory
oligodendrocytes, which also transiently express the A2B5 antigen early during
the transition from an OPC (Figure 1.1 B) (Sommer & Schachner 1981, Miller
1996). Post-migratory O4+ oligodendrocytes are morphologically distinct from
OPCs in that O4+ oligodendrocytes have multiple processes, as opposed to the
more simple bipolar morphology of OPCs. O4+ post-migratory oligodendrocytes
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send out a multitude of processes in search of their axonal targets regulated, in
part, by extracellular cues (Fox et al. 2006a).
The O4+ post-migratory oligodendrocytes keep their proliferative abilities
until they further differentiate into O1+ immature oligodendrocytes, which lack the
ability to proliferate but continue to mature morphologically (Figure 1.1 C) (Miller
1996). During development there is an overproduction of OPCs which are
pruned during this developmental stage based on the number and area of axons
available to be myelinated (Barres et al. 1992, Miller 2002).
With the expression of the appropriate transcription factors, O1+
oligodendrocytes further differentiate into myelinating oligodendrocytes, which
express myelin basic protein (MBP) and proteolipid protein (PLP) (Figure 1.1 D)
(Miller 1996, Sim et al. 2006). The myelinating oligodendrocytes will again
remodel their process morphology extensively, producing myelin membrane to
wrap axonal segments (Bauer et al. 2009, Kettenmann 2005).

Cytoskeletal rearrangement during oligodendrocyte development
The oligodendrocyte cytoskeleton is composed of mictrotubules and actin
microfilaments. The microtubular network is formed by α and β subunits that
dimerize and associate to form the characteristic cylindrical shape of a
microtubule and these individual microtubules associate to form a complex
mictrotubule cytoskeleton. The formation of microfilaments requires nucleation of
globular actin monomers into filamentous actin polymers which then associate to
form a comprehensive microfilament cytoskeleton. In general, process formation
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and extension occurs first by filopodia formation followed by widening of the
narrow fillopodial actin bundles to form lamellipodia and finally, the microfilament
structure is stabilized by invasion of polymerizing microtubules.
As discussed above, during development oligodendrocytes undergo vast
morphological remodeling to transition from an OPC, with a limited process
network, to a highly complex immature oligodendrocyte, and finally to a fully
developed myelinating oligodendrocyte. These morphological transformations
are largely regulated by the cytoskeleton and molecules that mediate cytoskeletal
remodeling.
Tubulin destabilizing factors have been implicated in process formation
and outgrowth during the extensive morphological changes of the
oligodendrocyte process network throughout development (Bauer et al. 2009,
Southwood et al. 2007, Richter-Landsberg 2008). While the microtubule
cytoskeleton has been shown to be involved in oligodendrocyte process
formation, the actin cytoskeleton has been shown to be of great significance for
initial cytoskeletal remodeling leading to oligodendrocyte process morphological
remodeling (Song et al. 2001).
The most studied molecules involved in directly regulating the actin
cytoskeleton in oligodendrocytes are the Rho family GTPases RhoA, Cdc42 and
Rac1 (Bacon et al. 2007, Czopka et al. 2009). These molecules are found
particularly associated with branch points and the tips of oligodendrocyte
processes, areas in which actin is also enriched (Song et al. 2001).
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Signals, such as netrin-1, regulate the actin cytoskeleton in opposing ways
depending on the stage of oligodendrocyte development. Early during
development netrin-1 signaling prevents OPC differentiation and process
extension through activation of RhoA, which promotes process retraction
(Rajasekharan et al. 2010). Later in oligodendrocyte differentiation, however, the
same netrin-1 signal leads to reduced RhoA activation which allows for
oligodendrocyte process branching and expansion of the process network
(Rajasekharan et al. 2010). The mechanism involved in the switch of GTPase
regulation associated with signals such as netrin-1 is currently not known.
The Src family kinases (SFK) member, Fyn, also promotes
oligodendrocyte process extension and differentiation during later stages of
development via inactivation of RhoA (Wolf et al. 2001). RhoA activity has,
however, been linked to enhanced membrane sheet formation in MBP+ mature
oligodendrocytes in vitro without affecting the differentiation program of the
oligodendrocytes (Czopka et al. 2009). These findings suggest a highly complex
role for RhoA-mediated cytoskeletal remodeling during oligodendrocyte
development.
Unlike RhoA, the GTPases Rac and Cdc42 have been shown to be
involved in promoting oligodendrocyte process extension and enhancing
differentiation in vitro (Liang et al. 2004, Hall 1998). While there is no apparent
effect on oligodendrocyte development upon Cdc42 or Rac knockout in vivo,
there is an increase in the amount of myelin out-foldings and a reduction in
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myelin thickness, which points to a role for cytoskeletal modification in
appropriate myelin formation (Thurnherr et al. 2006).
Oligodendrocyte process extension in vitro and initiation of myelination in
vivo have been shown to involve signaling from neural-Wiskott Aldrich Syndrome
protein (N-WASP) which activates the actin related protein 2/3 (Arp2/3) complex
(Bacon et al. 2007). The Arp2/3 complex functions to promote actin nucleation
and could play a role in lamellipodia formation during oligodendrocyte process
remodeling and initial myelination (Bauer et al. 2009).
As described above, molecular interactions which regulate the actin
cytoskeleton are crucial for proper and timely myelination. The precise
regulatory mechanisms of these complex interactions are still largely unknown;
however, focal adhesions, and particularly FAK, have been highly implicated in
cell-ECM signaling regulating cytoskeletal rearrangement.

Focal adhesions: what they are and how they work
Throughout development changes of the ECM environment induce cellular
responses. There are various ways that cells can sense and relate to the
environment; however via focal adhesion is the most common. Focal adhesions
are intracellular multi-molecular complexes of about 1-10 μm2 in size that
associate with cell membrane receptors and allow ECM interaction with the cell’s
cytoskeleton (Badley et al. 1980).
In any given focal adhesion there are certain required constituents for
proper function. Every adhesion site requires a link to the ECM, usually in the
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form of an integrin receptor. Integrin receptors also serve as scaffolding proteins
that associate with various signaling molecules during focal adhesion formation
and turnover (Schwartz & Ingber 1994, Giancotti & Ruoslahti 1999, Playford &
Schaller 2004). Other focal adhesion proteins, such as SFKs, are primarily
necessary for their catalytic function but also serve to mediate the association of
interacting molecules within the focal adhesion (Cobb et al. 1994, Cary et al.
2002, Schwartz & Ingber 1994). A large molecular complex of this magnitude
involves so many signaling pathways and therefore requires extensive regulation
to mediate proper ECM signal transduction. In this regard FAK has been shown
to function as a major regulator and integrator of focal adhesion signaling (Mitra
et al. 2005, Parsons 2003).

Focal adhesion kinase (FAK)
FAK is a ubiquitously expressed 125 kDa non-receptor protein tyrosine
kinase that was characterized by Steve Hanks, Jun-Lin Gaun, and Michael
Schaller in 1992 (Schaller et al. 1992, Guan & Shalloway 1992, Hanks et al.
1992). FAK plays a key role in integrin-mediated focal adhesion signaling.
During association of integrin receptors with ECM proteins FAK activity is
enhanced via both autophosphorylation and transphosphorylation by SFKs (Mitra
et al. 2005, Schlaepfer et al. 1999, Guan & Shalloway 1992, Hanks & Polte
1997).
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FAK FERM domain
FAK contains an N-terminal FERM (FAK N-terminal ezrin/radixin/moesin
homology) domain which binds growth factor receptors such as PDGFαR (Mitra
et al. 2005, Parsons 2003, Schlaepfer et al. 1999). This domain does not,
however, appear to play a large role in integrin-stimulated focal adhesion
dynamics (Mitra et al. 2005). FAK has a central kinase domain that is located
just outside of its FERM domain only having ~40% homology to the catalytic
domains of other protein tyrosine kinases making it a rather unique non-receptor
tyrosine kinase (Schaller et al. 1992).
FAK has many phosphorylation sites, both tyrosine and serine, that
modulate its activity, however since tyrosine phosphorylation has been more
closely linked to ECM-mediated adhesion function the serine residues will not be
discussed (Schlaepfer & Hunter 1996). FAK is activated by autophosphorylation
on its Tyr397 site, which is within FAK’s kinase domain, leading to a
conformational change (Toutant et al. 2002, Zhou et al. 2006). This allows highaffinity binding for the Src-homology-2 (SH2) domain of SFKs (Hanks & Polte
1997). SFKs are involved in phosphorylating various other tyrosine residues,
including Tyr861 and Tyr925, allowing for full activation of FAK (Calalb et al.
1996, Schlaepfer & Hunter 1996). The Tyr576/577 sites stabilize FAK in an
active conformation and are two of the sites phosphorylated by SFKs (Cary et al.
2002, Hanks & Polte 1997). The kinase domain is also a binding site for the p85
subunit of phosphotidylinositol 3-kinase (PI3-Kinase) which promotes membrane
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ruffling and lamellipodia formation (Figure 1.2 red pathway) (Hamadi et al. 2005,
Clark et al. 1998).

FAK C-terminal domain (FRNK)
The FAK C-terminal domain contains two proline rich regions (PRR) that
bind to Src-homology-3 (SH3) domains of signaling proteins involved in focal
adhesion formation and turnover, including p130Cas (Figure 1.2 blue pathway),
which promotes cell migration by activation of Graf (Ras, GTPase regulator
associated with FAK), and ASAP1 (Arf GTPase-activation protein GAP 1) (Mitra
et al. 2005). ASAP1 has a role in regulating cell spreading as well as FAK
localization to focal adhesions since over expression leads to interruption of both
conditions (Figure 1.2 green pathway) (Liu et al. 2002).
Graf is highly expressed in the brain; however, it is inconclusive if Graf is
expressed by oligodendrocytes (Taylor et al. 1998). FAK’s association with Graf
allows Graf activation through phosphorylation by mitogen-activated protein
kinase (MAPK) (Taylor et al. 1998). Active Graf inactivates Rho by up regulating
the catalysis of Rho bound GTP (active form) to make RhoGDP (inactive form)
(Figure 1.2 teal pathway) (Taylor et al. 1998). Graf also inactivates Cdc42,
however, Rac is not affected by Graf activation which allows Rac to function
without the antagonistic effects of Rho (Taylor et al. 1998). Rac allows for
oligodendrocyte process outgrowth, focal adhesion formation, and morphological
differentiation and is has been shown to be up regulated during oligodendrocyte
differentiation (Clark et al. 1998, Liang et al. 2004).
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FAK FAT domain
FAK has a focal adhesion targeting (FAT) domain that is necessary for
FAK’s localization to focal adhesions (Contestabile et al. 2003, Mitra et al. 2005,
Schlaepfer et al. 1999).
The Tyr925 phosphorylation site is located within the FAT domain. The
adaptor protein Grb2 binds to phosphorylated Tyr925 linking FAK to the MAPK
signaling pathway which is involved in the regulation of various cellular functions
(Figure 1.2 yellow pathway) (Mitra et al. 2005, Schlaepfer et al. 1994, Schlaepfer
et al. 1999). Grb2 also binds dynamin on its proline rich domain (PRD), which is
important for microtubule-induced focal adhesion disassembly, especially in
migrating cells. Grb2 probably is the mediator between FAK and dynamin, which
allows FAK to relate with microtubule dynamics (Ezratty et al. 2005). In post
migratory premyelinating oligodendrocytes phosphorylation of the Tyr925 residue
is reduced compared to migrating OPCs (Fox et al. 2004).
The integrin-associated proteins talin and paxillin bind FAK on the FAT
domain (Mitra et al. 2005). Phosphorylation of paxillin promotes binding of Crk’s
SH2 domain, increasing Rac activity and stimulating cell motility as well as
process outgrowth (Figure 1.2 light blue pathway) (Clark et al. 1998). Paxillin
also associates with p120RasGAP, which decreases Rho activation through
activation of p190RhoGAP, leading to enhanced process outgrowth (Brown et al.
2005). The FAT domain also binds the Rho-family GTPase p190RhoGEF
allowing FAK to phosphorylate p190RhoGEF, activating it (Figure 1.2 orange
pathway). p190RhoGEF increases the exchange of RhoGDP for RhoGTP
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activating RhoA which leads to process retraction (Zhai et al. 2003). FAK
associates with both GEFS (GTPase activators) as well as GAPs (GTPase
inactivators) to allow for a cyclical regulation of both Rac, Cdc42 and Rho activity
by either activating or inactivating GTPases upstream of these molecules (Tomar
& Schlaepfer 2009). Via this cyclical regulation of GTPases FAK enables
processes to remain highly dynamic while encountering the ECM environment.

Life without FAK: FAK null
Unfortunately the main phenotype found in constitutive FAK null mice is
embryonic lethality due to general mesodermal growth defects (Ilic et al. 1995).
At this stage of development OPCs have not yet been specified therefore
research on FAK’s role in oligodendrocytes has been largely unknown.
Fibroblast and endothelial cells collected from FAK null mouse embryos have,
however, given some helpful clues as to FAK’s role in focal adhesion dynamics
and cytoskeletal rearrangement. FAK null fibroblasts still form focal adhesions
showing that FAK is not necessary for focal adhesion formation in fibroblasts;
however in neuronal cells FAK plays a role in both adhesion formation and
turnover (Mitra et al. 2005, Robles & Gomez 2006). Taken together FAK null
fibroblasts were found to display reduced focal adhesion turnover, increased
focal adhesion number and size, decreased motility, proliferation defects, actin
assembly and location defects, poor cell spreading, and enhanced tyrosine
phosphorylation throughout the adhesion (Jiang et al. 2006, Webb et al. 2004, Ilic
et al. 1995). The FAK null mice have a similar phenotype to those of ECM
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molecule, fibronectin null animals, demonstrating FAK’s necessity in ECMintegrin signaling (Ilic et al. 1995, George et al. 1993). Fibroblasts without FAK
also have higher than normal Rho activity, due to an inability to regulate Rho
activity, which could explain the decrease in cell motility and actin defects (Ren et
al. 2000). Even the reduction of FAK expression, rather than eliminating it
altogether, will dramatically reduce the cells ability to function properly (Jiang et
al. 2006, Hoshina et al. 2007).
Since Pyk2 is the only other known member of the focal adhesion kinase
family it stands to reason that Pyk2 might be compensating for any loss or
reduction of FAK. There is an increase in Pyk2 expression in fibroblasts and
endothelial cells that lack FAK, however, the functions lost along with FAK are
not entirely regained in the Pyk2 over-expressing cells (Schlaepfer et al. 1999,
Klingbeil et al. 2001). While there are additional effects of removing Pyk2 from
FAKnull cells (Sieg et al. 1998, Lim et al. 2008b) it appears that FAK is the main
player in focal adhesion dynamics and cytoskeletal remodeling.
As discussed in the above section FAK is associated with various
molecular regulators of cytoskeletal remodeling including, but not limited to, Rho,
Rac, Cdc42 and Ras. Phosphorylation by FAK is also involved in the localization
and activation of N-WASP, which leads to actin polymerization and
oligodendrocyte process extension and initial myelination, as discussed in the
previous section (Wu et al. 2004). Due to the high level of involvement for FAK
in regulating the cytoskeletal remodeling of the oligodendrocyte process network
during development we explored the effects of removing FAK from
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oligodendrocytes during a stage of extreme morphological remodeling, i.e. prior
to myelination.
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A) OPC

C) Immature
Oligodendrocyte

B) Post-migratory
Precursor

D) Mature
Oligodendrocyte

A2B5
PDGFαR
DM20

A2B5
O4

O4, O1,
MBP, PLP

O4, O1,
MBP, PLP

Migration
Proliferation

Proliferation
Pruning

Differentiating
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Figure 1.1 Development of an oligodendrocyte from a neuroepithelial cell to a
mature oligodendrocyte. A) oligodendrocyte precursor cells (OPC) which migrate
to their site of action and further differentiate into B) post-migratory precursor
oligodendrocytes which begin sending out processes. C) Immature
oligodendrocytes undergo drastic morphological maturation ultimately becoming
myelin-producing D) mature oligodendrocytes. Markers differentially expressed
throughout oligodendrocyte development: A2B5, Platelet derived growth factor α
receptor (PDGFαR), DM20, O4, O1, myelin basic protein (MBP), and proteolipid
protein (PLP). Adapted from Pfeiffer et al., 1993.
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Figure 1.2 Schematic of signaling pathways regulated by FAK via interactions
with focal adhesion molecules. FAK promotes cytoskeletal remodeling via
association of phosphotidylinositol 3-kinase (PI3K) with the kinase domain of
FAK (red pathway). The proline rich regions (PRR) of FAK associate with
p130Cas (blue pathway), GTPase regulator associated with FAK (GRAF; teal
pathway), and Arf GTPase-activation protein GAP1 (ASAP1; green pathway),
affecting various cellular functions primarily involved in cytoskeletal
rearrangement. Paxillin (light blue pathway), p190RhoGEF (orange pathway),
and Grb2 (yellow pathway) associate with the focal adhesion targeting (FAT)
domain of FAK and mediate process dynamics. Adapted from Schlaepfer et al.,
1999 and Parsons, 2003.
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Chapter 2
Focal Adhesion Kinase (FAK): A Regulator of CNS Myelination

(This chapter was accepted as a paper in the Journal of Neuroscience Research
in February of 2009. The work reported for this manuscript was preformed with
vital assistance from Dr. Ray Colello and Dr. Jeff Dupree.)

Introduction
During development of the central nervous system (CNS), differentiation
of oligodendrocytes, the myelinating cells, and the process of active myelination
itself are regulated by complex interactions of the oligodendrocytes' cell surfaces
with their extracellular environment (Lubetzki-Korn et al. 1983, Fridman et al.
1985, Notterpek & Rome 1994, Oh & Yong 1996, Buttery et al. 1999, Szuchet et
al. 2000, Siskova et al. 2006, Colognato et al. 2007). These interactions are
mediated to a large extent by the integrin class of extracellular matrix (ECM)
receptors. (Malek-Hedayat & Rome 1994, Milner & ffrench-Constant 1994, Frost
et al. 1999, Relvas et al. 2001, Colognato et al. 2002, Colognato et al. 2004,
Gudz et al. 2002, Baron et al. 2005, Olsen & ffrench-Constant 2005, Benninger
et al. 2006, Lee et al. 2006). In support of integrin-ECM signaling playing a
pivotal role in the regulation of oligodendrocyte differentiation and CNS
myelination, signaling molecules that are effectors in integrin-mediated signaling
cascades have also been implicated in these processes (Chun et al. 2003, Fox et
al. 2004, Liang et al. 2004, Hoshina et al. 2007, Sloane & Vartanian 2007).
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One of the main regulators of integrin-ECM signaling is focal adhesion
kinase (FAK). FAK, also known as protein tyrosine kinase 2, is a ubiquitously
expressed nonreceptor protein tyrosine kinase that can be activated by a number
of extracellular signals (Hanks et al. 1992, Schaller et al. 1992, Schlaepfer et al.
1999, Parsons 2003, Mitra et al. 2005, Mitra & Schlaepfer 2006). FAK has been
found to be expressed in cells of the oligodendrocyte lineage and is present in
myelin (Kilpatrick et al. 2000, Bacon et al. 2007). Interestingly, phosphorylation of
FAK at its Tyr397 site, which represents a critical event for its activation and
biological effects, has been described as occurring primarily in postmigratory
differentiating oligodendrocytes and not in migratory oligodendrocyte progenitor
cells (Liang et al. 2004). Furthermore, additional phosphorylation events of FAK
tyrosine residues regulate its overall function (Schlaepfer & Hunter 1996, Hanks
& Polte 1997, Cohen & Guan 2005). Phosphorylation of one of these residues,
namely, the Tyr925 residue, has been found to be significantly altered during the
initial stages of myelination (Fox et al. 2004). Taken together, these data suggest
a role for FAK in regulating oligodendrocyte maturation and/or CNS myelination
itself. However, this role of FAK has not yet been well characterized.
Ubiquitous FAK knockout is early embryonically lethal because of general
mesodermal defects (Furuta et al. 1995, Ilic et al. 1995). Therefore, to investigate
the potential role of FAK in the regulation of oligodendrocyte maturation and/or
CNS myelination, we generated oligodendrocyte-specific and inducible FAKknockout mice using the Cre-loxP system (Fakflox/flox: PLP/CreERT mice). Our
results revealed that when inducing FAK knockout in these mice just prior to and
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during the initial stages of myelination of the optic nerve, myelination was
reduced on postnatal day 14 (P14). In addition, our data showed that the
induction of FAK knockout resulted in a reduced number of primary
oligodendrocyte processes at this developmental age. However, this phenotype
appears to be transient because the number of myelinated fibers on postnatal
day 28 (P28) was comparable under both control and knockout conditions. Taken
together, these data demonstrate that FAK is involved in regulating the efficiency
and timing of myelination in its initial stages and suggest that this regulatory role
may involve the control of oligodendrocyte process outgrowth and/or remodeling.

Materials and Methods

Animals and Induction of FAK Knockout
Mice in which the second kinase domain exon of Fak is flanked by loxP
sites (Fakflox/flox mice) were bred to mice that express, under the control of the
proteolipid protein (PLP) promoter, Cre recombinase fused to a tamoxifeninducible mutated ligand-binding domain of the human estrogen receptor
(PLP/CreERT mice, kindly provided by B. Popko, University of Chicago; (Beggs
et al. 2003, Doerflinger et al. 2003). Both strains are on a C57BL/6 genetic
background. Litters used for the present study were derived from males
homozygous for the floxed Fak locus and heterozygous for the PLP/CreERT
locus and females homozygous for the floxed Fak locus but negative for the
PLP/CreERT locus. Thus, knockout and control mice were derived from the same
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breeding pairs. To induce FAK knockout, 300-µL intraperitoneal injections of 3
mg of tamoxifen or vehicle (sunflower oil) were administered daily into lactating
mothers from postnatal day 2 (P2) through P12, with P0 referring to the day of
birth (Leone et al. 2003). Animals were analyzed at P14 and P28. To confirm
successful Cre-mediated recombination under the above-described conditions,
PLP/CreERT mice were additionally bred to Gt(ROSA)26Sortm1(EYFP)Cos reporter
mice, which contain an enhanced yellow fluorescent protein (EYFP) gene
inserted into the Gt(ROSA)26Sor locus and are also on a C57BL/6 genetic
background (Jackson Laboratory, Bar Harbor, ME; see also (Srinivas et al.
2001). In these reporter mice, expression of EYFP is blocked by an upstream
loxP-flanked STOP sequence and only induced on successful Cre-mediated
recombination at the ROSA26 locus. Gt(ROSA)26Sortm1(EYFP)Cos:PLP/CreERT
mice were treated as described above and analyzed at P14. All animal studies
were approved by the Institutional Animal Care and Use Committee at Virginia
Commonwealth University.
PCR Analysis
For genotype analysis, DNA was extracted from tail clips using a DNeasy
blood and tissue kit (Qiagen, Valencia, CA). For analysis of recombination
efficiency upon tamoxifen treatment, optic nerves were dissected from P14
animals, and DNA was extracted as described above. Polymerase chain reaction
(PCR) was performed using a Taq PCR Core Kit (Qiagen, Valencia, CA) and a
PTC-200 DNA Engine Cycler (MJ Research, Waltham, MA). The following primer
pairs were used at the indicated annealing temperatures: CreERT forward (5-
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GATGTAGCCAGCAGCATGTC-3) and CreERT reverse (5ACTATATCCGTAACCTGGAT-3) at 50°C and FAK-flox-P1 (5GACCTTCAACTTCT CATTTCTCC-3) and FAK-flox-P2 (5-GAATGCTACAG
GAACCAAATAAC-3) at 55°C. Custom oligonucleotides were obtained from
MWG-Biotech (Huntsville, AL). The PCR cycling conditions were: 2 min at 94°C,
followed by 35 cycles of amplification (45 sec at 94°C; 1 min, 30 sec at the
respective annealing temperature; and 45 sec at 72°C) and 4 min of extension at
72°C. Amplified DNA was analyzed using agarose gel electrophoresis and the
VersaDoc 4000 imaging system (Bio-Rad, Hercules, CA).

Immunohistochemistry
Immunohistochemistry was performed on longitudinal sections of optic
nerves dissected from tamoxifen-treated P14
Gt(ROSA)26Sortm1(EYFP)Cos:PLP/CreERT mice. Mice were deeply anesthetized,
transcardially perfused with 4% paraformaldehyde in 0.1M Millonigs buffer (150
mM sodium phosphate monobasic/100mM sodium hydroxide) and postfixed for
24 hr. Optic nerves were removed, cryoprotected in 30% sucrose/PBS,
embedded in Tissue-Tek on dry ice, and 10-µm sections were then cut on a
Shandon SME Cryotome (Thermo Scientific, Philadelphia, PA). Sections were
immunolabeled after a permeabilization step in ice-cold acetone (Dupree et al.
1999) using the following antibodies: mouse monoclonal anti-APC/CC1
(EMD/Calbiochem, Gibbstown, NJ), rabbit polyclonal anti-GFP/YFP (Millipore,
Temecula, CA), and secondary Alexa Fluor 594-conjugated donkey antimouse
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IgG and Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen/Molecular
Probes, Carlsbad, CA). Sections were analyzed by confocal microscopy using a
Leica TCS SP2 AOBS System (Leica Microsystems Inc., Bannockburn, IL).

Light and Electron Microscopic Analysis
P14 and P28 mice treated with either tamoxifen or sunflower oil were
deeply anesthetized and transcardially perfused with 4% paraformaldehyde/2.5%
glutaraldehyde in 0.1M Millonigs buffer (Dupree et al. 1998). Mice were postfixed
for 1-2 weeks in aldehyde fixative. Optic nerves were dissected out and
incubated for 1 hr in 1% osmium tetroxide/0.1M Na-cacodylate buffer (Electron
Microscopy Sciences, Ft. Washington, PA). Specimens were dehydrated with
ethanol and embedded in Epon resin (Electron Microscopy Sciences, Ft.
Washington, PA).
For light microscopic analysis, semithin (1-µm) transverse sections were
taken every 1 mm throughout the length of the optic nerve, stained with toluidine
blue, and imaged using a Nikon ECLIPSE E800M microscope equipped with a
Spot RT CCD camera (Nikon Inc., Melville, NY). The number of myelinated fibers
was determined in a blinded fashion for each entire transverse section. The
average number for the control sections was set to 100%, and each value was
calculated accordingly. Statistical significance was determined using the
Student's t test.
For electron microscopic analysis, ultrathin transverse sections (90 nm)
were taken 1 mm from the lamina cribrosa and at 1-mm intervals along the length
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of the optic nerve. Sections were collected on Formvar-coated slotted grids and
stained with uranyl acetate and lead citrate. Images were taken using a JEOL
JEM1230 transmission electron microscope equipped with an Ultrascan 4000
Gatan CCD camera.

Results

Administration of Tamoxifen to Lactating Females Induces Cre-Mediated
Recombination in the Optic Nerve and in Cells of Oligodendrocyte Lineage
in Early Postnatal Offspring Containing the PLP/CreERT Locus
To determine the in vivo role of FAK in differentiating oligodendrocytes
during the developmental period of myelination, spatially and temporally
controlled transgenic FAK-knockout mice were generated using an inducible CreloxP system. More specifically, mice in which the second kinase domain exon of
Fak is flanked by loxP sites (Fakflox/flox mice; Figure 2.1B) were bred to mice that
express, under the control of the PLP promoter, Cre recombinase fused to a
tamoxifen-inducible mutated ligand binding domain of the human estrogen
receptor (PLP/CreERT mice; Figure 2.1B; (Beggs et al. 2003, Doerflinger et al.
2003)). Because of the breeding strategy used (see Materials and Methods
section), all mice analyzed for the potential effects of FAK-knockout induction
were homozygous for the floxed Fak locus and either heterozygous for the
PLP/CreERT locus (Fakflox/flox:PLP/CreERT mice) or lacking the PLP/CreERT locus
(Fakflox/flox littermate controls). It has been previously established that only upon
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administration of tamoxifen is CreERT translocated from the cytoplasm to the
nucleus, where it is able to catalyze recombination at loxP sites (Leone et al.
2003). In addition, it has been shown that the PLP promoter used for the
generation of the PLP/CreERT mice is well suited to direct transgene expression
to differentiating oligodendrocytes (Wight et al. 1993, Fuss et al. 2000, Fuss et al.
2001, Doerflinger et al. 2003). Thus, the use of the above-described Fakflox/flox:
PLP/CreERT mice allowed for design strategies in which to induce Cre-mediated
recombination and thus FAK knockout specifically in differentiating
oligodendrocytes and during the developmental period of active myelination.
Because of the region-specific timing of active myelination in the CNS, however,
individual knockout, that is, tamoxifen injection, strategies need to be employed
for specific CNS regions (Caley & Maxwell 1968, Foran & Peterson 1992, Leone
et al. 2003, Thomson et al. 2005).
For the study presented here, we chose the optic nerve as the anatomical
region of interest because of its relatively simple morphology and the welldescribed chronology of oligodendrocyte differentiation and myelination (Skoff et
al. 1976a, Skoff et al. 1976b, Skoff et al. 1980, Tennekoon et al. 1977,
Hildebrand & Waxman 1984, Hunter & Bedi 1986, Butt & Ransom 1993, Colello
et al. 1995, Thomson et al. 2005). In the optic nerve of developing C57Bl/6 mice,
that is, animals of genetic background similar to that of the Fakflox/flox:PLP/CreERT
mice, both oligodendrocyte differentiation and myelination proceed from the
retinal to the chiasmatic end of the nerve (Thomson et al. 2005). First axonal
contact of oligodendrocyte processes can be seen at the retinal end around
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postnatal day 6 (P6). At this point, oligodendrocytes also begin to express the
PLP isoform of PLP/DM20 and are thus considered to represent a myelinating
stage of the lineage (Tennekoon et al. 1977, Trapp et al. 1997, Thomson et al.
2005). At the chiasmatic end, such initially myelinating cells are first observed at
P8. Mature, that is, compacted, myelin can be found extended over the whole
length of the nerve around P15 (Foran & Peterson 1992). Thus, to induce Cremediated recombination in the optic nerve just prior to and during the
developmental period of active myelination, tamoxifen or sunflower oil as vehicle
control were administered daily to lactating mothers from 2 to 12 days
postpartum, and animals were analyzed during the active stages of myelination,
that is, at P14, and at a mature stage, that is, at P28 (Figure 2.1A). Successful
Cre-mediated recombination at the Fak locus was assessed by PCR analysis
(Figure 2.1C). Recombination could be observed as early as P4 (data not
shown). At this point, oligodendrocytes in the optic nerve for the most part are at
a progenitor stage, at which they express low levels of FAK (Liang et al. 2004).
Thus, even in a case of a relatively stable FAK protein, FAK protein levels will be
reduced upon FAK-knockout induction because it inhibits the normal
developmental up-regulation of FAK expression. At P14, approximately 40% of
the cells in the optic nerve are oligodendrocytes (Barres et al. 1992). Thus, the
recombination efficiency of approximately 40% observed in our studies (Figure
2.1C) suggests efficient Cre-mediated recombination in cells of the
oligodendrocyte lineage, at least at this developmental age. In the other cell
types of the optic nerve, which are primarily astrocytes, the PLP promoter is not
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operative, and thus recombination cannot be induced upon administration of
tamoxifen. To further confirm successful Cre-mediated recombination in cells of
the oligodendrocyte lineage under the conditions depicted in Figure 2.1A,
PLP/CreERT mice were bred to Gt(ROSA)26Sortm1(EYFP)Cos reporter mice, in
which expression of EYFP is blocked by an upstream loxP-flanked STOP
sequence and only induced upon successful Cre-mediated recombination
(Srinivas et al. 2001). As a marker for cells of the oligodendrocyte lineage, an
antibody to cytoplasmic APC/CC1 was used (Bhat et al. 1996, Fuss et al. 2000).
As shown in Figure 2.1D, EYFP expression could easily be detected in
APC/CC1-positive cells of the optic nerve of a tamoxifen-treated P14
Gt(ROSA)26Sortm1(EYFP)Cos:PLP/CreERT mouse. Taken together, the above data
confirm that under the conditions depicted in Figure 2.1A, Cre-mediated
recombination at loxP sites occurs efficiently in the optic nerve and in cells of the
oligodendrocyte lineage during early postnatal development (P4-P14) of offspring
containing the PLP/CreERT locus.

At P14, the Number of Myelinated Axons is Decreased in Optic Nerves of
Tamoxifen-Treated Fakflox/flox:PLP/CreERT Mice
To assess the extent to which FAK may regulate developmental
myelination, we determined the number of myelinated fibers in tamoxifen-treated
Fakflox/flox: PLP/CreERT and control mice at P14 using light microscopy (Figure
2.2). To eliminate the possibility that varying levels of myelination along the
length of the optic nerve affect the outcome of our analysis, we examined
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sections taken at 1-mm intervals along the whole length of the nerve (Skoff et al.
1980). At all levels, the number of myelinated fibers was found to be reduced in
the Fakflox/flox:PLP/CreERT mice compared with their Fakflox/flox litter mates (see
example in Figure 2.2A). When averaging the number of myelinated fibers for all
levels, these were found to be significantly decreased, by more than 30%, in
Fakflox/flox:PLP/CreERT mice compared to Fakflox/flox mice (Figure 2.2B,C). No such
differences were noted when analyzing vehicle-treated Fakflox/flox: PLP/CreERT
and Fakflox/flox mice (data not shown).
To determine the resolution of our type of analysis, we compared semithin
sections (light microcopy) with consecutive ultrathin sections (electron
microscopy). As shown in Figure 2.3, such analysis revealed that visualizing
transverse sections of the optic nerve using light microscopy allowed myelinated
axons enwrapped with as few as four layers of myelin to be distinguished. Thus,
our data demonstrate that FAK is involved in the regulation of the initial steps of
myelination and/or myelin wrapping.

At P14, the Number of Primary Oligodendrocyte Processes is Reduced in
Optic Nerves of Tamoxifen-Treated Fakflox/flox:PLP/CreERT Mice
To further investigate the above role of FAK during developmental
myelination of the optic nerve, we determined the total number of cells in the
semithin 1-µm transverse sections taken at 1-mm intervals (measured from the
lamina cribrosa). This analysis revealed no differences between P14
Fakflox/flox:PLP/CreERT mice and their Fakflox/flox littermates (Figure 2.4A),
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suggesting that the effect of FAK-knockout induction on myelination may not be a
result of changes in the number of oligodendrocytes. However, when analyzing
the number of primary processes, that is, processes that directly extend from
oligodendrocyte cell bodies, a significant decrease, of approximately 30%, was
observed in P14 Fakflox/flox: PLP/CreERT optic nerves compared to optic nerves
from P14 Fakflox/flox littermates (Figure 2.4B-D). Oligodendrocyte cell bodies can
be easily distinguished from cell bodies of the major other cell type found in the
optic nerve, namely, astrocytes, as astrocytes exhibit abundant glycogen
granules and contain intermediate filaments. Thus, we are confident that to a
large extent, our analysis was restricted to oligodendrocytes. Taken together, the
above data therefore suggest that the decrease in the number of myelinated
fibers seen upon induction of FAK knockout is a result, at least in part, of
impaired oligodendrocyte process outgrowth and/or remodeling.
At P28, the Number of Myelinated Axons within Optic Nerves is
Comparable Between Tamoxifen-Treated Fakflox/flox and
Fakflox/flox:PLP/CreERT Mice
To assess the extent to which the above-observed effects of FAKknockout induction during periods of active myelination are persistent into
adulthood, we determined the number of myelinated axons at P28. At this age,
the number of myelinated axons in the optic nerve was found to be comparable
between Fakflox/flox and Fakflox/flox:PLP/CreERT mice (Figure 2.5). These data
suggest that the role of FAK may be of particular importance for the efficiency
and timing of the initial stages of myelination.
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Discussion
In the present study, we have demonstrated that induction of FAK
knockout just prior to and during active stages of myelination results in
hypomyelination in the optic nerve at a time-point when normally myelinated
fibers can be found extended throughout the whole length of the nerve, that is, at
P14. Furthermore, our data suggest that this effect of FAK-knockout induction is
a result at least in part of reduced outgrowth and/or impaired remodeling of
primary oligodendrocyte processes. However, myelination appears to have
reached normal levels by P28. Thus, our data suggest that in vivo in the optic
nerve, FAK promotes efficient and properly timed myelination during the active
phases of myelin sheath formation.
In light of the known role of FAK in integrating ECM-integrin signaling
events, our data are in support of the previously suggested but somewhat
controversial regulatory role of integrin signaling during CNS myelination (Relvas
et al. 2001, Benninger et al. 2006, Lee et al. 2006, Colognato et al. 2007).
Furthermore, they are in good agreement with findings that demonstrated
developmental myelination to be controlled by signals up- and downstream of the
integrin-FAK axis, such as laminin2/ merosin and Fyn, respectively (Biffiger et al.
2000, Sperber et al. 2001, Chun et al. 2003). Interestingly, expression of
dominant-negative β1 integrin, laminin2/merosin deficiency, and Fyn knockout all
result in hypomyelination in a region-specific manner, with only the optic nerve
affected to a similar extent in these mutant mice. Thus, the roles of ECM
proteins, integrins, and FAK may differ in different CNS areas. Those areas

34

potentially not controlled by FAK may depend on the FAK-related kinase prolinerich tyrosine kinase 2 (Pyk2). Although Pyk2 expression in oligodendrocytes has
not been well defined, it represents a good candidate for functionally substituting
FAK (Avraham et al. 2000, Klingbeil et al. 2001, Orr & Murphy-Ullrich 2004,
Nakamura et al. 2007). However, future studies will be necessary to dissect the
exact roles of FAK and Pyk2 in the regulation of CNS myelination.
FAK has been characterized as a regulator of morphological remodeling
and, in particular, has been implicated in the regulation of process outgrowth
from both neurons and oligodendrocytes (Beggs et al. 2003, Falk et al. 2005,
Robles & Gomez 2006, Hoshina et al. 2007). Our data demonstrating a reduction
in the number of primary processes on induction of FAK knockout are consistent
with these previous findings. A pivotal role of FAK in the regulation of
morphological oligodendrocyte differentiation is further supported by the fact that
Fyn, a known FAK effector, has been found to be important for the development
of the extensive oligodendrocyte process network (Osterhout et al. 1999, Buttery
& ffrench-Constant, Klein et al. 2002, Liang et al. 2004). In the case of Fyn, this
morphological maturation can be regulated independent of changes in gene
expression typically associated with oligodendrocyte differentiation (Osterhout et
al. 1999). The extent to which FAK is involved in the control of gene expression
in differentiating oligodendrocytes, however, has not yet been characterized.
Nevertheless, the above data support the idea that impaired process outgrowth
and/or remodeling, at least in part, may be responsible for the hypomyelination
seen in the optic nerves of tamoxifen-treated Fakflox/flox:PLP/CreERT mice.
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In our studies, the effect of FAK-knockout induction on myelination was
found to be transient, with normal levels of myelination detectable at P28. Thus,
FAK's role appears to mainly affect the efficiency and timing of myelination.
However, as discussed above, Pyk2 may be able to substitute FAK's function not
only in a region-specific manner but also in the case of loss of FAK. Future
studies will be necessary to assess such a potentially important role of Pyk2 in
myelination.
Taken together, our data suggest that FAK promotes efficient and properly
timed myelination in the optic nerve, where it likely acts as an effector of integrin
signaling activated by oligodendrocyte-ECM interactions. Our data further
suggest that this signaling event promotes process outgrowth and potentially
remodeling during the initial stages of myelination. Impairment of these steps of
oligodendrocyte maturation appears to be responsible for, at least in part, the
limited repair of the myelin sheath seen in lesions of patients suffering from the
major demyelinating disease in humans: multiple sclerosis (Chang et al. 2002,
Franklin & ffrench-Constant 2008, Kuhlmann et al. 2008). Thus, increasing the
understanding of the role of FAK in CNS myelination not only furthers our
understanding of normal CNS development but may also reveal novel targets
suitable to stimulate remyelination under pathological demyelinating conditions.
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Figure 2.1 Induction of Cre-mediated recombination in Fakflox/flox:PLP-CreERT
and Gt(ROSA)26Sortm1(EYFP)Cos:PLP-CreERT mice. A: Injection paradigm used to
induce Cre-mediated recombination at the floxed fak or ROSA26 locus just prior
to and during myelination of the optic nerve. Times of initial myelination defined
as described by Thomson et al. 2005 (Thomson et al. 2005). B: Schematic at the
top depicts the transgene construct used to generate the PLP/CreERT mice
(Doerflinger et al. 2003). The PLP cassette contains 2.4 kb of the 5’-flanking
DNA, exon 1 and intron 1 of the Plp gene. The cDNA sequence coding for
CreERT was inserted 3’ of intron 1. For transcription termination, a simian virus
(SV) 40 poly(A) signal sequence was added. Middle schematic depicts the floxed
Fak locus, in which the second kinase domain exon of Fak is flanked by loxP
sites (Beggs et al. 2003). Upon crossbreeding and tamoxifen application,
recombination at the Fak locus was induced as depicted in the bottom schematic.
P1 and P2 indicate the location of PCR primers used for genotyping. C: PCR
analysis of recombination at the Fak locus in optic nerves of tamoxifen-treated
Fakflox/flox:PLP-CreERT and Fakflox/flox mice at P14. Primers P1 and P2 depicted in
A were used, and the amount of each amplification product was determined
using the VersaDoc 4000 imaging system (Bio-Rad, Hercules, CA). Bar graph
depicts means ± SEM (n = 3 per genotype); *, statistically significant as
determined by Student's t test. D: Representative confocal images of P14 optic
nerve sections taken from tamoxifen-treated Gt(ROSA)26Sortm1(EYFP)Cos: PLPCreERT mice after double-labeling for APC/CC1 and YFP. Nuclei were stained
using Hoechst. Images depict single channel representations of a single optical
section (approximately 0.2-µm x-z resolution). Scale bar = 10 µm
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Figure 2.1
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Figure 2.2 Reduced number of myelinated fibers in optic nerves of tamoxifentreated Fakflox/flox:PLP/CreERT mice at P14. A: Numbers of myelinated fibers
within entire transverse sections of P14 optic nerves at approximately 1, 2, and 3
mm from the lamina cribosa. Mean for all control values was set to 100%, and
percentages for all data points were calculated accordingly. Results for a
representative optic nerve littermate pair are shown. B: Numbers of myelinated
fibers averaged over all three intervals of the optic nerve. Percentages were
calculated as described in A. Bar graph depicts means ± SEM (n = 3 per
genotype); *, statistically significant as determined by the Student's t test. C:
Representative pictures of semithin sections from Fakflox/flox (left) and
Fakflox/flox:PLPCreERT (right) optic nerves taken at approximately 1, 2, and 3 mm
from the lamina cribosa. Scale bars = 10 µm.
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Figure 2.2

40

Figure 2.3 Resolution (visual threshold) for the detection of a myelinated fiber in
the optic nerve was approximately 4 layers of myelin at the light microscopic
level. A: Semithin section of the optic nerve imaged at the light microscopic level.
Scale bar = 10 µm. B, C: Ultrathin sections taken immediately adjacent to the
semithin section shown in A and imaged at the electron microscopic level. Scale
bar = 2 µm (B) and 200 nm (C). Rectangle in A marks the area shown in B ( *,
myelinated fibers that can be identified as such at both the light and the electron
microscopic levels; Δ, myelinated fiber that can only be identified as such at the
electron microscopic level).
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Figure 2.4 Reduced number of primary oligodendrocyte processes in optic
nerves of tamoxifen-treated Fakflox/flox:PLP/CreERT. A: Total number of cells
counted at light microscopic level in semithin P14 optic nerve sections at the 1mm interval (see Figure 2.2). Mean for all control values was set to 100%, and
percentages for all data points were calculated accordingly. Bar graph depicts
means ± SEMs (n = 3 per genotype). B: Number of primary processes per cell
counted at electron microscopic level and over an entire transverse section for
each nerve analyzed. Mean for all control values was set to 100%, and
percentages for all data points were calculated accordingly. Bar graph depicts
means ± SEMs (n = 3 per genotype, 258 cells for each condition); *, statistically
significant as determined by the Student's t test. C, D: Representative
transmission electron micrographs for a Fakflox/flox:PLP/CreERT (D) and a
Fakflox/flox (C, control) oligodendrocyte. Scale bars = 2 µm.

42

Figure 2.5 Comparable number of myelinated fibers in optic nerves of tamoxifentreated Fakflox/flox and Fakflox/flox:PLP/CreERT mice at P28. Numbers of myelinated
fibers were determined within entire transverse sections of optic nerves at
approximately 1 mm from the lamina cribosa and as described in Figure 2.2.
Mean for all control values was set to 100%, and percentages for all data points
were calculated accordingly. Bar graph depicts means ± SEMs (n = 3 per
genotype).
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Chapter 3
FAK associated mediators of oligodendrocyte cytoskeletal remodeling

Integrins
Integrins are ubiquitously expressed transmembrane heterodimer
receptors formed from the combination of one of eighteen possible α chains and
one of eight possible β chains. Each subunit (α and β) is composed of a single
transmembrane domain, to tether the integrin to the membrane, a large
extracellular domain, which interacts with ECM ligands, and a cytoplasmic
domain, that interacts with signaling molecules, such as FAK, within the cell
(Zamir & Geiger 2001, Romer et al. 2006).
Activation of integrins involves a conformational change which induces
receptor clustering allowing for further recruitment and activation of focal
adhesion molecules (Ye et al. 2010, Schwartz & Ingber 1994). Signaling through
integrins is a bidirectional process with information traveling in an outside-in
(signals sent from the extracellular environment are transduced into reactions by
the cell) or inside-out (signals originating within the cell affect a change in the
integrin signaling to various other molecules which then leads to other cellular
reactions) direction (Romer et al. 2006). One of the signaling molecules most
commonly activated by integrin signaling is FAK (Buttery et al. 1999).
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Integrins in developing oligodendrocytes
To date five heterodimer pairs of integrins have been shown to be
expressed on the membranes of oligodendrocytes: α6β1, αvβ1, αvβ3, αvβ5, and
αvβ8 (Milner & ffrench-Constant 1994, Buttery et al. 1999, Baron et al. 2005).
The fibronectin/ vitronectin receptor αvβ1 integrin is highly expressed in OPCs
then declines drastically with differentiation while αvβ3 integrin is most highly
expressed following OPC differentiation and prior to myelin sheet formation in
vitro (Milner & ffrench-Constant 1994, Milner et al. 1997, Blaschuk et al. 2000,
Baron et al. 2005). Fibronectin and vitronectin along with growth factor signaling,
such as PDGFα, acting through the αvβ1 integrin receptor enhance OPC
migration while signaling through αvβ3 integrin is more important for OPC
proliferation (Lee et al. 2006, Baron et al. 2005). The other
fibronectin/vitronectin-binding integrin, αvβ5, replaces the declining αvβ1 integrin
during early oligodendrocyte differentiation. The expression of αvβ5 increases
with differentiation and is found associated with PLP (Milner & ffrench-Constant
1994, Blaschuk et al. 2000, Gudz et al. 2002).
Early oligodendrocytes have been shown to contain integrin aggregates
composed mainly of αvβ3 integrin (Cluzel et al. 2005). The Lyn SFK associates
with αvβ3 on OPCs, however there has been little investigation into Lyn’s role
during oligodendrocyte differentiation and myelination (Klein et al. 2002,
Colognato et al. 2004).
Various in vivo studies have been preformed to elucidate the role of the
different integrin subunits during oligodendrocyte development. The most

45

commonly studied subunit is the β1 integrin subunit due to its constitutive
presence during oligodendrocyte development. Studies have been contradictory
until recently. Region specific myelin deficits and decreases in oligodendrocyte
differentiation have been reported in mice expressing inactive forms of the β1
integrin, (Barros et al. 2009, Lee et al. 2006) while in mice with an early knock
out of β1 expression no myelin defects were reported (Benninger et al. 2006).
These contradictory findings have been theorized by ffrench-Constant to be due
to differences in experimental design. In the inactive β1 expresser studies there
could be an exaggeration of the phenotype since the inactive integrin might outcompete other receptors. While the knockout study could have eliminated β1
from the system at an early point during development thus allowing
compensatory mechanisms to take affect. Due to these possibilities ffrenchConstant preformed a study in which a dominant negative β1 integrin (a fusion
protein containing the intracellular β1 domain bound to the nonsignaling human
interleukin-2 extracellular domain) under control of a later stage oligodendrocyte
promoter (MBP) was expressed in mice (Camara et al. 2009). In these mice a
transient myelin deficit was observed specifically affecting small-diameter fibers
and a decrease in FAK signaling was seen (Camara et al. 2009). As mentioned
in chapter 2 these results were in line with what we had previously observed in
our FAK-null mice. These results insinuate a role for integrin signaling, possibly
through FAK, in initial myelin formation during development.
Throughout development oligodendrocytes express the α6β1 integrin,
which binds laminin-2 (Baron et al. 2005). This integrin receptor is involved in
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oligodendrocyte survival throughout development, possibly by associating with
an antigen on the membrane surface of adjacent astrocytes (Gudz et al. 2002,
Frost et al. 1999, Corley et al. 2001). The β1 integrin of this heterodimer seems
to play a large role during myelination, since reducing the expression of β1
inhibits the activation of Rac and Cdc42 thus inhibiting oligodendrocyte
morphological maturation and decreasing the number of oligodendrocytes
exhibiting mature membranes in vitro (Buttery & ffrench-Constant 1999, Liang et
al. 2004). Oligodendrocytes grown only on laminin-2 (the substrate for integrin
α6β1) also have greater process extension and an increased membrane
formation (Buttery & ffrench-Constant 1999).
The binding of laminin-2 to α6β1 integrin activates the SFK, Fyn, which is
expressed by oligodendrocytes throughout development (Grant et al. 1995, Klein
et al. 2002, Colognato et al. 2004). Fyn associates with FAK and activates
p190RhoGAP by tyrosine phosphorylation allowing the upregulation of Cdc42
and Rac activity, which increases process extension in vitro (Figure 1.2, peach
pathway) (Wolf et al. 2001, Liang et al. 2004, Cobb et al. 1994, Cary et al. 1996).
Fyn is highly expressed in oligodendrocytes during differentiation and
myelination and is found associated with myelin membrane microdomains (Klein
et al. 2002, Osterhout et al. 1999, Kramer et al. 1999). There is increased Fyn
expression in more differentiated, premyelinating oligodendrocytes than in OPCs
leading to the conclusion that Fyn may be more functional in process outgrowth
and myelination than migration and proliferation of oligodendrocytes (Colognato
et al. 2004).
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While Fyn may not be needed for general growth and differentiation,
without Fyn mice have impaired myelination and a reduced number of
oligodendrocytes throughout development with less complexity in the
oligodendrocytes that do survive (Ponniah et al. 1999, Sperber & McMorris 2001,
Colognato et al. 2004, Sperber et al. 2001, Biffiger et al. 2000). Fyn null mice
also have reduced levels of phosphorlyated FAK (Grant et al. 1995).
It has been shown that β1-integrin inhibition decreases the activity of Fyn
and disrupts oligodendrocyte differentiation (Liang et al. 2004). It appears that
Fyn, activated by association with α6β1 integrin in the focal adhesion, instigates
FAK’s association with many proteins via tyrosine phosphorylation. These FAKmediated molecular associations activate various proteins including Rac and
Cdc42 which then lead to increased oligodendrocyte process outgrowth and
morphologic differentiation (Colognato et al. 2004, Wolf et al. 2001, Liang et al.
2004).

Extracellular matrix in the CNS
The ECM is the conglomeration of various molecules, which allow cells to
respond appropriately to environmental cues primarily via rearrangement of the
cytoskeleton. Major constituents of the CNS ECM are hyaluronic acid and
proteoglycans, as well as tenascins and adhesion-associated ECM molecules,
such as fibronectin and laminin-2 (Sobel 1998, Bronner-Fraser 1986). It has
been well characterized that a change in the ECM environment affects the
morphology of developing oligodendrocytes (Notterpek & Rome 1994, Fridman et
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al. 1985, Oh & Yong 1996). The most well characterized ECM molecules
involved in oligodendrocyte morphological remodeling are fibronectin and
laminin-2; therefore we will focus on these two molecules henceforth.
In vitro studies have linked fibronectin signaling to enhanced OPC
proliferation and migration (Hu et al. 2009). This fibronectin-mediated promotion
of OPC proliferation requires Lyn activity (Colognato et al. 2004). Fibronectin is
also involved in keeping OPCs from differentiating too early during development
(Hu et al. 2009). More differentiated oligodendrocytes in association with
fibronectin have a smaller, less mature process morphology (Olsen & ffrenchConstant 2005, Liang et al. 2004). This restriction of the oligodendrocyte
process network has been shown to involve RhoA activation (Liang et al. 2004).
The effect of fibronectin on oligodendrocyte process morphology could be due to
issues with membrane-directed transport since oligodendrocytes plated on
fibronectin have transport issues that are alleviated when integrin signaling, and
hence the signaling of fibronectin is blocked (Siskova et al. 2006).
Laminin-2 is the ECM ligand for two receptors expressed by
oligodendrocytes, α6β1 integrin and dystroglycan (Colognato et al. 2007, Buttery
& ffrench-Constant 1999) and is found in direct opposition to unmyelinated axons
during development (Colognato et al. 2002). Laminin-2 is involved in growthfactor induced oligodendrocyte survival and enhanced oligodendrocyte
differentiation (Baron et al. 2005, Colognato et al. 2002). The laminin-mediated
promotion of oligodendrocyte survival and differentiation requires Fyn activity and
α6β1 integrin function (Colognato et al. 2004, Camara et al. 2009).
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While fibronectin plays a role in holding oligodendrocytes in a less mature
morphology laminin-2 is involved in promoting a mature oligodendrocyte process
morphology and myelin sheath formation (Buttery & ffrench-Constant 1999,
Olsen & ffrench-Constant 2005, Sypecka et al. 2009). In vivo animals with
mutations of laminin-2 have a reduction in oligodendrocyte differentiation and a
reduced number of myelinated small diameter axon fibers in various regions of
the CNS (Chun et al. 2003, Relucio et al. 2009). The laminin-mediated effects on
oligodendrocyte morphology and myelin formation require integrin-mediated PI3K
and integrin linked kinase (ILK) activity (Chun et al. 2003). The laminin-induced
effect on myelin formation appears to be, at least in part, mediated by the
dystroglycan receptor, however little is known about the exact effects of laminin-2
association with dystroglycan receptors (Colognato et al. 2007). Fyn and FAK
activity have been shown to be enhanced and appears to be required for laminin2’s affect on oligodendrocyte morphology and myelination (Relucio et al. 2009,
Hoshina et al. 2007).
Although FAK is a well known integrator of cell-ECM interactions, the
involvement of FAK in the ECM-mediated effects on oligodendrocyte morphology
during development, as discussed above, has remained a mystery. To unravel
this mystery we utilized an in vitro system which allows for stringent control of the
oligodendrocyte developmental stage as well as the ECM environment.
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Chapter 4
Focal adhesion kinase (FAK) can play unique and opposing roles in
regulating the morphological maturation of differentiating oligodendrocyte

(This chapter will be submitted as a paper to the Journal of Neurochemistry.)

Introduction
Focal adhesion kinase (FAK), also known as protein tyrosine kinase 2
(PTK2), is a ubiquitously expressed non-receptor tyrosine kinase that functions
as an important regulator of cell shape and adhesion in response to
environmental signals (Mitra et al. 2005, Parsons 2003, Schaller 2010, Hanks &
Polte 1997, Schlaepfer et al. 1999). In particular, components of the extracellular
matrix (ECM) are known to interact with transmembrane receptors of the integrin
family and to subsequently recruit FAK to intracellular multi-molecular
complexes, termed focal adhesions (Berrier & Yamada 2007, Giancotti &
Ruoslahti 1999, Geiger et al. 2009, Schaller et al. 1992). FAK-containing focal
adhesions function as key sensory machineries that integrate extracellular
signals, interconnect them with the cell’s actin cytoskeleton and thus ultimately
mediate complex cellular responses.
In the central nervous system (CNS) FAK expression has long been
recognized to occur in neurons (Burgaya et al. 1995, Burgaya & Girault 1996,
Burgaya et al. 1997, Grant et al. 1995, Stevens et al. 1996, Contestabile et al.
2003). Only more recently, however, its expression was characterized in cells of
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the oligodendrocyte lineage (Bacon et al. 2007, Kilpatrick et al. 2000).
Oligodendrocytes, the myelin forming cells of the CNS, undergo extensive
morphological remodeling when they differentiate from migratory bipolar
oligodendrocyte precursor cells to post-migratory premyelinating
oligodendrocytes that extend a complex process network and finally to mature
oligodendrocytes that generate the myelin sheath (Pfeiffer et al. 1993, Baumann
& Pham-Dinh 2001, Jackman et al. 2009). Completing these distinct steps of
morphological maturation requires extensive remodeling of the cytoskeleton
(Wang et al. 2008, Bacon et al. 2007, Kim et al. 2006, Miyamoto et al. 2007,
Sloane & Vartanian 2007, Song et al. 2001, Bauer et al. 2009, Richter-Landsberg
2008, Southwood et al. 2007, Liang et al. 2004). Thus, FAK, as a key player in
regulating cytoskeletal organization, is likely involved in the regulation of
oligodendrocyte differentiation and myelination. Indeed, FAK has been found to
mediate process outgrowth from cells of the rat-derived oligodendrocyte cell line
CG4 (Hoshina et al. 2007). In addition, phosphorylation of FAK at its
autophosphorylation site, which represents a critical event for FAK’s activation
and catalytic function, has been described to occur primarily in post-migratory
differentiating oligodendrocytes and to a lesser extent in migratory
oligodendrocyte progenitor cells, suggesting a role for FAK primarily in maturing
cells of the oligodendrocyte lineage (Liang et al. 2004). Furthermore, FAK has
been implicated in a number of signaling pathways regulating oligodendrocyte
differentiation (Wang et al. 2009, Rajasekharan et al. 2009, Miyamoto et al. 2007,
Fox et al. 2004). Most importantly, both our lab and ffrench-constant’s lab
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recently documented that conditional knock-out of FAK in maturing
oligodendrocytes results in an inhibition and/or delay of normal developmental
myelination (Camara et al. 2009, Forrest et al. 2009). Taken together, these
studies highlight the importance of FAK in regulating myelination. However, the
molecular mechanisms mediated by FAK in maturing oligodendrocytes
underlying the observed phenotype in the conditional FAK knock-out mice are
not fully understood.
Morphological maturation of cells of the oligodendrocyte lineage occurs in
the context of a diverse extracellular environment. In particular two ECM proteins
have been characterized with regard to their importance in oligodendrocyte
differentiation and myelination, namely fibronectin and laminin-2. Both are
present in the CNS during the time of normal developmental myelination (see
Figure 4.7b). Fibronectin has been detected in the developing CNS in a likely
diffuse manner, while non-basal lamina laminin-2 was found to be present on the
axonal surface (Tom et al. 2004, Colognato et al. 2002, Zhao et al. 2009).
Functionally, fibronectin was found to attenuate process outgrowth in
oligodendrocytes, while laminin-2 has been implicated in stimulating myelin
sheath formation (Buttery & ffrench-Constant 1999, Chun et al. 2003, Buttery &
ffrench-Constant 2001, Olsen & ffrench-Constant 2005, Laursen & ffrenchConstant 2007, Colognato et al. 2005, Siskova et al. 2009, Maier et al. 2005).
The opposing effects seen in the presence of fibronectin versus laminin-2 raise
the question of whether either one or both ECM protein’s effects require FAK and
how these effects may relate to the in vivo phenotype seen in the conditional
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FAK knock-out mice.
In an attempt to better understand the role of FAK, as an integrator of
ECM signaling, the current study investigated the role of FAK on the
morphological maturation of post-migratory premyelinating oligodendrocytes in
the presence of fibronectin and laminin-2 in a well defined in vitro system. The
data presented here demonstrate the unique and opposing roles of FAK that are
dependent on the ECM substrate present and on the developmental stage of the
maturing oligodendrocytes. Thus, these data provide novel insight into the role of
FAK and they highlight the multi-functionality of FAK in the context of
developmental myelination.

Materials and methods

Antibodies
Hybridoma clone A2B5 (ATCC, Manassas, VA) was used for
immunopanning of oligodendrocyte progenitor cells. Hybridoma clone O4 (gift
from S. Pfeiffer) was used to identify post-migratory, premyelinating
oligodendrocytes (Sommer & Schachner 1981, Bansal et al. 1989). Anti-MBP
(SMI99; Covance, Princeton, NJ) was used for immunostaining. Anti-laminin
alpha2, anti-fibronectin, anti-GAPDH, anti-FAK (Millipore, Billerica, MA) anti-Fyn
and anti-Lyn (Cell Signaling, Beverly MA) antibodies were used for Western
blots. For all immunostainings, Alexa 594 or 488-conjugated antibodies
(Invitrogen/Molecular Probes, Carlsbad, CA) were used as secondary antibodies.
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Horseradish peroxidase (HRP)-labeled secondary antibodies (Vector
Laboratories, Burlingame, CA) were used for Western blots.

Animals
Sprague–Dawley female rats with early postnatal litters were obtained
from Harlan Laboratories (Indianapolis, IN). All animal studies were approved by
the Institutional Animal Care and Use Committee at Virginia Commonwealth
University.

Primary Oligodendrocyte cultures
Primary rat oligodendrocytes were isolated from postnatal (day 3 or 5) rat
brains as described previously (Barres et al. 1992, Fox et al. 2003). Briefly,
cerebral hemispheres were minced and incubated in Hanks balanced salt
solution supplemented with 0.25% trypsin (Invitrogen, Carlsbad, CA), and
1 μg/ml DNase (Sigma, St. Louis, MO). After titration, single cells were collected
by centrifugation, resuspended in Dulbecco's Modified Eagle Medium
(DMEM)/10% FCS (Invitrogen, Carlsbad, CA) and subjected to A2B5
immunopanning. Immunopanned cells were plated onto fibronectin (10 μg/ml)coated 6-well tissue culture dishes and cultured in serum-free proliferation
medium (DMEM containing 10ng/ml PDGF (R&D Systems; Minneapolis, MN)
and 5ng/ml bFGF (Sigma, St. Louis, MO); DMEM/PDGF/bFGF) for 15-20 hrs
followed by 20-24 hrs in differentiation medium (DMEM containing 40 ng/ml triiodo-thyronine (T3; Sigma, St. Louis, MO) and 1× N2 supplement (Invitrogen,
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Carlsbad, CA); DMEM/T3/N2). Cells were then trypsinized and re-plated onto
the various ECM substrates in the presence of differentiation medium and
cultured for an additional 20-24 hrs, at which time cells were analyzed.

siRNA-mediated knock-down of FAK expression
Oligodendrocytes were isolated by A2B5-immunopanning from postnatal
day 3 or 5 rat brains and plated onto fibronectin (10 μg/ml)-coated 6-well tissue
culture dishes. Cells were cultured in serum-free proliferation medium
(DMEM/PDGF/bFGF) for 15-20 hrs. Subsequently, cells were switched into
differentiation medium (DMEM/T3/N2) and siRNA transfected using lipofectamine
2000 (Invitrogen, Carlsbad, CA). For siRNA transfection a siGLO green
transfection indicator along with either a SMARTpool siRNA directed against rat
FAK or a control non-targeting SMARTpool siRNA, all obtained from Thermo
Fisher Scientifc/Dharmacon, Inc. (Lafayette, CO), were used. Transfection
medium containing siRNA-lipofectamine complexes was replaced with serumfree differentiation medium (DMEM/T3/N2) after 3 hrs and cells were cultured for
an additional 15-20 hrs. Subsequently, cells were re-plated onto fibronectin
(10 μg/ml), laminin-2 (10 μg/ml), or mixed substrate (5 μg/ml fibronectin and
5 μg/ml laminin-2)-coated glass coverslips and cultured for an additional 15-20
hrs. No significant reduction in total FAK protein levels was detected at the time
of replating (data not shown).
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PF573228-mediated FAK inhibition
Oligodendrocytes were isolated by A2B5-immunopanning from postnatal
day 3 or 5 rat brains and plated onto fibronectin (10 μg/ml)-coated 6-well tissue
culture dishes. Cells were cultured in serum-free proliferation medium
(DMEM/PDGF/bFGF) for 15-20 hrs followed by an additional 20-24 hrs in
differentiation medium (DMEM/T3/N2). Oligodendrocytes were then re-plated
onto fibronectin (10 μg/ml), laminin-2 (10 μg/ml), or mixed substrate (5 μg/ml
fibronectin and 5 μg/ml laminin-2)-coated glass coverslips, allowed to settle for 24 hrs and cultured in the presence of a specific inhibitor of FAK’s catalytic activity
(PF573228 (Tocris Bioscience, Bristol, England) at 100nM or 0.1% DMSO as
control). Cells were analyzed after an additional 15-20 hrs in culture.

Process morphology analysis
Process morphology was analyzed as previously described (Dennis et al.
2008). siRNA or FAK inhibitor-treated cells along with their respective control
cells were immunostained with O4 antibodies. For siRNA-treated cells only those
containing the siGLO green transfection indicator were analyzed. Images of at
least 25 cells were taken randomly for each treatment group in each experiment
(n ≥ 3) using an Olympus BX51 inverted fluorescent microscope (Olympus
America Inc., Center Valley, PA). IP Lab imaging software (BD Biosciences
Bioimaging, Rockville, MD) was used to determine process index (total area
found to be O4-positive minus the cell body) and network area (total area within
the radius of the process network surrounding the cell body minus the cell body).
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In addition, the number of primary processes (any process directly extending
from the cell body) was counted for each cell used for the above process
morphology analysis. For the bar graphs representing network areas, process
indices and primary process number the mean value for cells cultured under
control conditions was calculated. This mean value was set to 100% and
adjusted, i.e. normalized, values for all cells were averaged for each
experimental condition.
A confocal laser scanning microscopy (TCS SP2 AOBS, Leica
Microsystems, Exton, PA) was used for the generation of representative images.
Images represent 2D maximum projections of stacks of 0.4µm optical sections.

Live/Dead Viability Assay
siRNA or FAK inhibitor-treated cells were assayed for cell viability using
2µM calcein AM/4µM ethidium homodimer-1 as described by the manufacturer
(Live/Dead Viability Assay kit, Invitrogen Corp., Carlsbad, CA). Images of 8 fields
at 10X magnification were taken randomly for each treatment group in each
experiment (n = 3) using an Olympus BX51 inverted fluorescent microscope
(Olympus America Inc., Center Valley, PA). The percentage of live cells (labeled
with calcein) or dead cells (labeled with ethidium homodimer-1) was analyzed.
Bar graphs represent the mean value of live or dead cells under each
experimental condition.
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Results

For early stage post-migratory premyelinating oligodendrocytes, FAK plays
unique and opposing roles in regulating morphological maturation in the
presence of fibronectin versus laminin-2
The ECM substrates laminin-2 and fibronectin have been previously
described to differentially affect the maturation of post-migratory premyelinating
oligodendrocytes (Buttery & ffrench-Constant 1999, Buttery & ffrench-Constant
2001, Olsen & ffrench-Constant 2005, Siskova et al. 2006, Siskova et al. 2009).
To assess the effect of these ECM molecules in our tissue culture paradigm, we
compared network areas and process indices as described previously (Dennis et
al. 2008). In addition, we analyzed the effect of laminin-2 and fibronectin at two
developmental stages, namely early and later stage post-migratory
premyelinating oligodendrocytes. To obtain the early stage oligodendrocytes,
oligodendrocyte progenitor cells were isolated from postnatal day 3 rat brains by
A2B5 immunopanning and allowed to differentiate for 20-24 hours before replating onto the different ECM substrates. At the time of immunopanning,
oligodendrocyte progenitor cells express only the progenitor cell marker
recognized by the A2B5 antibody (Fox et al. 2004). In contrast, the cells hence
forth referred to as later stage post-migratory premyelinating oligodendrocytes
were isolated from postnatal day 5 rat brains by A2B5 immunopanning, at which
stage the majority of cells express both the early marker recognized by the A2B5
antibody as well as a later stage surface antigen recognized by the O4 antibody
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(Fox et al. 2004). As described above, cells were allowed to differentiate for 2024 hours before re-plating onto the different ECM substrates. In all cases, cells
were analyzed after an additional 20-24 hours of culture in differentiation
medium.
As shown in Figure 4.1, early stage oligodendrocytes plated on laminin-2
developed much larger network areas and process indices compared to
oligodendrocytes plated on fibronectin. Early stage oligodendrocytes on laminin2 revealed an increased occurrence of membrane sheet-like structures as
denoted by the arrows in Figure 4.1a (right panel). The later stage postmigratory premyelinating oligodendrocytes showed a similar effect (network area
fibronectin: 100%± 7, network area laminin-2: 155%± 10, p<0.05; process index
fibronectin: 100%± 7, process index laminin-2: 153%± 10, p<0.05) with an even
more obvious occurrence of membrane sheet-like structures (compare Figure
4.2c (left panel) with 3c (left panel)). Taken together, these studies demonstrate
that the effect of fibronectin versus laminin-2 on oligodendrocyte maturation is in
agreement with previous findings and that the effect of fibronectin versus laminin2 on oligodendrocyte maturation occurs for both early and later stage
oligodendrocytes and .
One of the major intracellular signaling molecules known to regulate
cellular morphology is the nonreceptor tyrosine kinase FAK. To determine the
extent to which FAK may play a role in mediating the differences in
oligodendrocyte maturation seen in cells plated in the presence of fibronectin or
laminin-2, early stage post-migratory premyelinating oligodendrocytes were
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treated with a siRNA pool against FAK or a non-targeting siRNA pool as a
control. Cells were cultured and analyzed as described above. As shown in
Figure 4.2a and b, siRNA-mediated FAK knock-down resulted in a significant
increase in both network area and process index for cells plated in the presence
of fibronectin. In addition, the number of primary processes was found to be
increased under these conditions. In contrast, when cells were plated in the
presence of laminin-2, all three parameters were found to be decreased upon
siRNA-mediated FAK knock-down (Figure 4.2c and d).
The effects on cell morphology described above were unlikely due to an
interference with initial cell spreading, since at the time of re-plating no significant
differences in FAK protein levels were noted (data not shown). At the time of
analysis, however, FAK protein levels were found decreased by approximately
50-60% in cells treated with the FAK-specific siRNA pool as compared to cells
treated with the control siRNA pool (see Figure 4.7a). It has been previously
demonstrated that FAK not only acts as a regulator of actin dynamics and cell
shape but can also be involved in signaling events controlling cell survival (Lim et
al. 2008a, Westhoff et al. 2004, Mitra et al. 2005, Cox et al. 2006). In addition,
elevated expression of Pyk2, a cytoplasmic tyrosine kinase closely related to
FAK, was found to functionally compensate for a loss of FAK and to cause
alterations beyond effects due to a loss of FAK in certain cell types under some
circumstances (Weis et al. 2008, Lim et al. 2008b, Sieg et al. 1998). Thus, we
assessed both cellular viability and Pyk2 protein levels. No significant differences
were observed at the time of analysis (see Figures 4.7a and 4.8a). These

61

findings suggest that FAK regulates morphological maturation of post-migratory
premyelinating oligodendrocytes without a significant change in cell viability or a
considerable compensatory increase in Pyk2 expression
During normal development morphological maturation of the
oligodendrocyte’s process network occurs concurrently with the establishment of
a protein expression profile characteristic for mature oligodendrocytes (Hardy et
al. 1996, Emery et al. 2009, Dugas et al. 2006). Under experimental conditions,
however, an independent regulation of these two processes has been observed
indicating that morphological and gene expression profile maturation may be
regulated by distinct molecular mechanisms (Buttery & ffrench-Constant 1999,
Osterhout et al. 1999, Sloane & Vartanian 2007, Younes-Rapozo et al. 2009). To
assess the extent to which the effect of siRNA-mediated FAK knock-down on cell
morphology was associated with a change in the oligodendrocyte’s protein
expression profile, the number of cells expressing one of the most extensively
studied proteins associated with oligodendrocyte maturation, namely myelin
basic protein (MBP), was determined. As shown in Figure 4.2e and f, no
significant changes in the number of the MBP-expressing cells were noted under
either of the conditions analyzed.
Thus, the above data demonstrate that FAK can regulate the morphology
of the early stage post-migratory premyelinating oligodendrocyte’s process
network in a unique and opposing manner depending on the ECM substrate
present. In particular, FAK limits the maturation of the oligodendrocyte’s process
network in the presence of fibronectin, while it promotes process maturation in
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the presence of laminin-2. In both cases, this regulation appears to be
independent of survival and/or the expression of myelin proteins.

For later stage post-migratory premyelinating oligodendrocytes,
morphological maturation is significantly less dependent on FAK in the
presence of fibronectin but still remains significantly controlled by FAK in
the presence of laminin-2
Our previous in vivo data demonstrated a significant decrease in the
number of primary processes upon induction of FAK knock-out; an effect
resembling the one seen in the presence of laminin-2 but not fibronectin for the
early stage post-migratory Premyelinating oligodendrocytes (Figure 4.2c and d).
The in vivo data were obtained from P14 optic nerves and thus at more
advanced developmental stages than those analyzed in Figure 4.2. Based on
these observations, we hypothesized that the role of FAK in regulating the
oligodendrocyte’s process network may change during developmental
maturation. To investigate this hypothesis, we treated and analyzed later stage
differentiating oligodendrocytes (isolated from postnatal day 5 rat brain) as
described above. Compared to the early stage post-migratory premyelinating
oligodendrocytes, the later stage cells were found to express similar levels of
FAK mRNA and protein (our unpublished data and (Dugas et al. 2006)). In
addition, there was no significant difference in the efficiency of siRNA-mediated
FAK knock-down between the two stages of oligodendrocytes (Figure 4.7a).
Furthermore, as observed for the early stage post-migratory premyelinating
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oligodendrocytes, viability and Pyk2 expression remained unchanged in the later
stage cells upon siRNA-mediated FAK knock-down (Figures 4.7b and 4.8b).
Unlike the early cells, however, there was no discernable change in the
later stage post-migratory Premyelinating oligodendrocyte’s process network
morphology in the presence of fibronectin upon siRNA-mediated FAK knockdown (Figure 4.3a and b). In contrast, in the presence of laminin-2 the later stage
differentiating oligodendrocytes displayed a similar change in the process
network morphology as seen for the early stage post-migratory premyelinating
oligodendrocytes (compare Figure 4.2c and d with Figure 4.3c and d). As was
observed for the early stage oligodendrocytes there was no notable change in
the number of MBP expressing oligodendrocytes under either of the conditions
(Figure 4.2e and f and 4.3e and f).
The above data demonstrate that with developmental maturation, FAK
looses its capacity to and/or effectiveness in regulating the process network
morphology of post-migratory pre-myelinating oligodendrocytes in the presence
of fibronectin. FAK’s role in enhancing process network morphology in the
presence of laminin-2, however, appears to remain unchanged.

For early stage post-migratory premyelinating oligodendrocytes, FAK’s
constraining role for morphological maturation appears to predominate
while for later stage oligodendrocytes FAK’s stimulatory role seems to
prevail
Both, fibronectin and laminin-2 have been found present in the developing
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CNS during oligodendrocyte maturation (Figure 4.8g and (Fox et al. 2004,
Colognato et al. 2002, Tom et al. 2004). Thus, we wished to determine the role of
FAK for the morphological maturation of post-migratory premyelinating
oligodendrocytes under conditions in which both fibronectin and laminin-2 are
present in the environment. Early and later stage post-migratory premyelinating
oligodendrocytes were cultured, treated and analyzed as described above, with
the exception that cells were re-plated on a mixed substrate of equal
concentrations of fibronectin and laminin-2 (instead of the individual substrates).
Interestingly, even though FAK was found to regulate morphological maturation
of early stage post-migratory premyelinating oligodendrocytes in an opposing
manner on fibronectin versus laminin-2, its role on the mixed substrate appeared
to be a primarily constraining one, i.e. similar to the one observed on fibronectin
alone (Figure 4.4a and b). For the later stage post-migratory premyelinating
oligodendrocytes, in which FAK appeared to have lost its capacity and/or
effectiveness in regulating the process network morphology in the presence of
fibronectin, the role of FAK was expectedly a stimulatory one, i.e. similar to the
one seen on laminin-2 alone (Figure 4.4c and d).
These data suggest that during the developmental maturation of postmigratory premyelinating oligodendrocytes FAK’s role switches from a
predominantly morphology restraining to a mostly morphology enhancing one.
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FAK’s unique and opposing roles in regulating morphological maturation
of post-migratory premyelinating oligodendrocytes are mediated by its
catalytic activity
FAK’s role in regulating morphological remodeling in various cell types has
at least in vitro been well documented to depend on its catalytic activity, i.e.
autophosphorylation (Parsons 2003, Hanks et al. 2003, Playford & Schaller 2004,
Schlaepfer et al. 1999, Cary et al. 1996). However, recent in vitro and in vivo
studies highlight the importance of both catalytic-dependent and catalyticindependent mechanisms in mediating FAK’s physiological functions (Corsi et al.
2009, Lim et al. 2008a, Cance & Golubovskaya 2008). To assess the extent to
which the above described effects of FAK in oligodendrocyte maturation were
dependent on its catalytic activity, we used the FAK kinase inhibitor PF573228.
This inhibitor has been shown in a variety of cell types to effectively block FAK
autophosphorylation and downstream signaling without significantly affecting cell
survival (Slack-Davis et al. 2007, Chen et al. 2009). Thus, to prevent potential
effects of initial cell spreading differentiating oligodendrocytes were treated with
PF573228 following re-plating. As described previously, treatment with
PF573228 did not significantly affect the viability of differentiating
oligodendrocytes (see Figure 4.9).
As shown in Figure 4.5, for both early and later stage post-migratory
premyelinating oligodendrocytes treatment with PF573228 resulted in changes in
cell morphology similar to the ones seen upon FAK knock-down. A concentration
of 100 nM was reported to yield approximately half-maximal inhibition of FAK
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autophosphorylation in various cell types (Slack-Davis et al. 2007). Thus, in both
paradigms, siRNA-mediated FAK knockdown and PF573228 pharmacological
inhibition, residual FAK activity likely remains. These data, therefore, suggest
that a significant downregulation of FAK expression and/or FAK catalytic activity
is sufficient to block the majority of FAK’s roles in regulating morphological
maturation of differentiating oligodendrocytes. Interestingly, however, for later
stage post-migratory pre-myelinating oligodendrocytes treatment with PF573228
in the presence of fibronectin resulted in a slight increase in the number of
primary processes, while network area and process index remained unchanged.
FAK’s role in limiting initial process outgrowth in later stage post-migratory premyelinating oligodendrocytes in the presence of fibronectin seems to be
particularly sensitive to the inhibition of FAK’s catalytic activity.

Discussion
The current study demonstrates that FAK can regulate morphological
maturation of post-migratory premyelinating oligodendrocytes in a unique and
opposing fashion that is dependent on the nature of the ECM substrate present
(i.e. fibronectin or laminin-2) and that is, for the most part, mediated by FAK’s
catalytic activity. In addition, the regulatory role of FAK in the morphological
maturation of post-migratory premyelinating oligodendrocytes was found to be
tightly regulated with the cell’s stage of maturation. More specifically, for the early
stage post-migratory premyelinating oligodendrocytes FAK’s constraining role on
morphological maturation predominated, while its stimulatory role prevailed for
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the later stage oligodendrocytes (see Figure 4.6). Taken together, the data
presented here provide novel insight into the complex role that FAK plays in
regulating the morphological maturation of differentiating oligodendrocytes in the
context of developmental changes and spatial differences in the molecular
composition of the extracellular environment.
FAK’s role in limiting the establishment of an expanded process network in
the presence of fibronectin was found to be significantly diminished for later
stage post-migratory premyelinating oligodendrocytes (see Figure 4.6).
Fibronectin receptors αvβ1, αvβ3, αvβ5 and αvβ8 integrins are expressed and
present on the surface of oligodendrocytes at all developmental stages (Milner &
ffrench-Constant 1994, Milner et al. 1997, Cahoy et al. 2008, Dugas et al. 2006).
Thus, while the functional role of FAK in the presence of fibronectin likely
involves the activation of integrin type receptors, it seems unlikely that a reduced
expression of fibronectin receptors is the primary cause of the observed
reduction in FAK-mediated function for the later stage cells. It, therefore, appears
to be the signaling pathway downstream of FAK that is altered in the more
mature cells. Due to the complex nature of FAK-containing signaling complexes,
multifaceted studies will be necessary to better understand the molecular
mechanism responsible for the developmental difference observed here.
Interestingly, it has been previously reported that FAK can also limit the
size of the axonal arbor for a variety of neuronal cell types (Rico et al. 2004). In
addition, FAK has been found to limit the length and number of dendritic
protrusions (Moeller et al. 2006, Shi et al. 2009). Both functions of FAK were
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found to be, at least in part, dependent on FAK’s catalytic activity. Most
importantly, FAK was implicated in controlling the establishment of the final
pattern of connections between neurons and their targets by enabling efficient
pruning of overproduced and/or ‘weak’ connections. With regard to the findings
described here, it is, therefore, tempting to speculate that the process network
limiting function of FAK observed in the presence of fibronectin, an ECM
molecule that is expressed broadly during development, allows for efficient
pruning of ‘non-functional’ oligodendroglial processes and represents part of the
regulatory mechanism that determines the final number of myelinated segments
that are generated by an individual mature oligodendrocyte.
In contrast to FAK’s process network limiting role discussed above, its role
in stimulating the establishment of a more mature morphology in the presence of
laminin-2 remained unchanged during the maturation of post-migratory
premyelinating oligodendrocytes and was thus found to predominate for the later
stage cells. Due to the more restricted presence of laminin-2 on the axonal
surface (Colognato et al. 2002), this function of FAK may play a more spatially
confined role than the one seen in the presence of fibronectin. Notably, the
interaction between laminin-2 and the integrin receptor α6β1 has been well
demonstrated to be involved in regulating the morphological maturation of postmigratory premyelinating oligodendrocytes in vitro and in vivo (Camara et al.
2009, Lee et al. 2006, Buttery et al. 1999, Barros et al. 2009, Relvas et al. 2001,
Olsen & ffrench-Constant 2005, Chun et al. 2003, Colognato et al. 2002, Laursen
& ffrench-Constant 2007). Most importantly, hypomyelinating phenotypes
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observed upon reducing α6β1 integrin signaling in maturing oligodendrocytes
resemble those seen upon inducing FAK knock-out in maturing oligodendrocytes
(Camara et al. 2009, Forrest et al. 2009). Thus, in the presence of laminin-2 FAK
likely functions as a downstream target of laminin-2-α6β1 integrin interactions. In
addition to regulating morphological maturation of differentiating
oligodendrocytes laminin-2-α6β1 integrin interactions have been described to
promote the transition from oligodendrocyte progenitor cells to mature MBPexpressing oligodendrocytes and to enhance survival of oligodendrocytes in
response to limiting concentrations of growth factors (Colognato et al. 2007,
Frost et al. 1999, Baron et al. 2005, Colognato et al. 2002). However, no
significant changes in the number of MBP-expressing or surviving cells were
noted in the studies presented here. These finding are in agreement with the
data obtained from conditional FAK knock-out mice, in which no obvious changes
in the number of cells were noted (Forrest et al. 2009). Thus, FAK is unlikely to
play a significant role in regulating myelin protein gene expression and/or survival
for post-migratory premyelinating oligodendrocytes as a downstream target of
laminin-2-α6β1 integrin interactions. This interpretation may be supported by the
discovery that the src family kinase (SFK) regulatory proteins Csk and Cbp are
critically involved in mediating the transition from oligodendrocyte progenitor cells
to MBP-expressing oligodendrocytes downstream of laminin-2-α6β1 integrin
interactions (Colognato et al. 2004, Relucio et al. 2009). Taken together, these
findings, therefore, strongly suggest a crucial role of FAK in regulating the
morphological maturation of post-migratory premyelinating oligodendrocytes by
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functioning as a downstream target of spatially restricted laminin-2-α6β1 integrin
interactions that affect the organization of the cell’s cytoskeleton. Interestingly,
dystroglycan has been recently identified as a second laminin receptor
functionally involved in promoting oligodendrocyte maturation and myelination
(Colognato et al. 2007). However, knock-down of dystroglycan was found to
significantly affect both myelin gene expression as well as morphological
maturation of oligodendrocytes. Thus, it is unclear to what extent laminin-2dystroglycan interactions may contribute to the FAK-mediated mechanism
described here.
The role of FAK in regulating oligodendrocyte morphology in the presence
of both fibronectin and laminin-2 was seen to be largely dependent on FAK’s
catalytic activity. Phosphorylation of FAK at its autophosphorylation site creates a
high affinity binding site for Src-homology 2 (SH2) domain containing proteins, in
particular SFKs (Mitra et al. 2005, Mitra & Schlaepfer 2006, Parsons 2003, Cobb
et al. 1994). The binding of SFKs to FAK can lead to the formation of a FAKactivated SFK complex, which has the capability to act as a regulator of cell
shape. In addition, it has been demonstrated that FAK can directly phosphorylate
SFKs at their Y418 activation site (Wu et al. 2008). Two SFKs have been
described to be expressed at significant levels in maturing oligodendrocytes,
namely Fyn and Lyn (Colognato et al. 2004, Osterhout et al. 1999, Kramer et al.
1999). In agreement with these studies, both Fyn and Lyn were found expressed
in post-migratory premyelinating oligodendrocytes at the maturation stages
analyzed here (see Figure 4.8c-f). The SFK Fyn has been well documented to be
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involved in regulating morphological maturation of differentiating
oligodendrocytes via the laminin-2-α6β1 integrin pathway (Colognato et al. 2004,
Relucio et al. 2009). Taken together with the data presented here, morphological
maturation of post-migratory premyelinating oligodendrocytes appears to be
mediated by the concerted action of FAK and Fyn as downstream targets of
laminin-2-α6β1 integrin interactions (see also (Hoshina et al. 2007). In contrast
to the laminin receptor α6β1 integrin, which has been shown to associate with
Fyn, the fibronectin receptor αvβ3 integrin was found to associate with the SFK
Lyn and not Fyn (Colognato et al. 2004). This association has been functionally
implicated in the regulation of PDGF-mediated oligodendrocyte progenitor cell
proliferation. The data presented here, could indicate an additional role, i.e. a role
in negatively regulating the morphological maturation of post-migratory
premyelinating cells via a fibronectin-αvβ3 integrin-FAK-Lyn pathway.
The current study provides novel insight into the complex and diverse
roles that FAK can play in regulating the morphological maturation of postmigratory premyelinating oligodendrocytes. In vivo FAK knock-out was found to
lead to a delay in myelination, a phenotype that is associated with a reduction in
the number of primary oligodendroglial processes (Camara et al. 2009, Forrest et
al. 2009). Based on the data presented here, this phenotype appears, at least in
part, to be due to a lack of FAK’s maturation promoting role in the presence of
laminin-2. In the context of demyelinating diseases, such as Multiple Sclerosis,
FAK, therefore, presents itself as a good therapeutic target for promoting
remyelination. However, demyelinated lesions are characterized by an
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extracellular environment that is different from the one found in the developing
CNS. In particular, high levels of fibronectin were noted in lesions of Multiple
Sclerosis patients (Satoh et al. 2009, van Horssen et al. 2007, Sobel & Mitchell
1989). Thus, FAK signaling may, at least in part, contribute to the limited repair
seen in such lesions. Taken together, the findings presented here highlight the
complexity of FAK’s role in regulating the maturation of post-migratory
premyelinating oligodendrocytes, and they emphasize the importance of a better
understanding of the signaling pathways involving FAK in order to be able to
design effective therapeutic strategies for promoting remyelination under
pathological demyelinating conditions.
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Figure 4.1 Morphological maturation of post-migratory premyelinating
oligodendrocytes is uniquely regulated in the presence of fibronectin or laminin-2.
Oligodendrocyte progenitor cells were isolated by A2B5 immunopanning from
postnatal day 3 rat brains. After 2 days in culture, differentiating oligodendrocytes
were re-plated onto fibronectin (Fn) or laminin-2 (Ln)-coated glass coverslips and
allowed to differentiate for 20-24 hours. (a) Representative images of cells
stained with the O4 antibody. (b) Bar graphs depicting quantitative analyses of
the total area occupied by the cells’ process network (network area; left graph)
and the total area of O4-positive process surfaces per cell (process index; right
graph). Mean control network areas and process indices were set to 100% and
all values were adjusted accordingly. Means and standard errors are shown.
Four independent experiments were performed and 25 cells per experiment were
analyzed. For both parameters, Student’s t-test analysis revealed an overall twotailed significance level of p<0.05 (indicated by the star). Scale Bar: 20 μm.
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Figure 4.2 siRNA-mediated knock-down of FAK expression affects
morphological maturation of early stage post-migratory premyelinating
oligodendrocytes distinctively and in an opposing fashion in the presence of
fibronectin or laminin-2. Cells were isolated, differentiated and analyzed as
described in Figure 4.1. Cells were, however, treated with a control siRNA pool
(siControl) or a siRNA pool against FAK (siFAK) 15-20 hours after initial plating.
(a) Representative images of cells stained with the O4 antibody and plated in the
presence of fibronectin (Fn). (b) Bar graphs representing quantitative analyses of
network areas, process indices and primary process numbers of cells plated in
the presence of fibronectin (Fn). (c) Representative images of cells stained with
the O4 antibody and plated in the presence of laminin-2 (Ln). (d) Bar graphs
representing quantitative analyses of network areas, process indices and primary
process numbers of cells plated in the presence of laminin-2 (Ln). (e)
Representative images of cells stained with an antibody specific for myelin basic
protein (MBP) (left panels) and with Hoechst to visualize nuclei (left panels). (e)
Bar graph representing the percentage of Hoechst-positive cells that are also
MBP-positive. In all bar graphs, means and standard errors of at least three
independent experiments (25 cells each for all conditions) are shown. Stars
indicate an overall two-tailed significance level of p<0.05 as determined by
Student’s t-test analysis. Scale Bars: 20 μm (in a and b), 50 μm (in e).
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Figure 4.2
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Figure 4.3 siRNA-mediated knock-down of FAK expression fails to affect
morphological maturation of later stage post-migratory premyelinating
oligodendrocytes in the presence of fibronectin but still affects maturation in the
presence of laminin-2. Later stage oligodendrocytes were isolated, differentiated,
treated and analyzed as described in Figure 4.2. (a) Representative images of
cells stained with the O4 antibody and plated in the presence of fibronectin (Fn).
(b) Bar graphs representing quantitative analyses of network areas, process
indices and primary process numbers of cells plated in the presence of
fibronectin (Fn). (c) Representative images of cells stained with the O4 antibody
and plated in the presence of laminin-2 (Ln). (d) Bar graphs representing
quantitative analyses of network areas, process indices and primary process
numbers of cells plated onto laminin-2 (Ln) as substrate. (e) Representative
images of cells stained with an antibody specific for myelin basic protein (MBP)
(left panels) and with Hoechst to visualize nuclei (left panels). (e) Bar graph
representing the percentage of Hoechst-positive cells that are also MBP-positive.
In all bar graphs, means and standard errors of at least three independent
experiments (25 cells each for all conditions) are shown. Stars indicate an overall
two-tailed significance level of p<0.05 as determined by Student’s t-test analysis.
Scale Bars: 20 μm (in a and b), 50 μm (in e).
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Figure 4.3
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Figure 4.4 siRNA-mediated knock-down of FAK expression in the presence of a
mixed fibronectin/laminin-2 substrate affects morphological maturation of early
and later stage post-migratory premyelinating oligodendrocytes in a distinctive
and opposing fashion. Cells were isolated, differentiated, treated and analyzed
as described in Figure 4.2. (a,c) Representative images of cells stained with the
O4 antibody. Early stage post-migratory premyelinating oligodendrocytes are
shown in (a), while (c) depicts later stage cells. Scale Bars: 20 μm. (b,d). Bar
graphs representing quantitative analyses of network areas, process indices and
primary process numbers. Means and standard errors of at least three
independent experiments (25 cells each for all conditions) are shown. Stars
indicate an overall two-tailed significance level of p<0.05 as determined by
Student’s t-test analysis.
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Figure 4.5 Inhibition of FAK’s catalytic activity affects morphological maturation
of early and later stage post-migratory premyelinating oligodendrocytes in a
similar fashion as siRNA-mediated knock-down of FAK expression. Cells were
isolated, differentiated and analyzed as described in Figures 4.1. Cells were,
however, treated with the FAK inhibitor PF573228 (PF228; 100 nM)) or vehicle
(control; 0.1% DMSO) (a,b). Bar graphs representing quantitative analyses of
network areas, process indices and primary process number of early (in a) and
later (in b) stage post-migratory premyelinating oligodendrocytes in the presence
of fibronectin (Fn) or laminin-2 (Ln). Means and standard errors of at least three
independent experiments (25 cells each for all conditions) are shown. Stars
indicate an overall two-tailed significance level of p<0.05 as determined by
Student’s t-test analysis.
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Figure 4.6 Proposed model for the role of FAK in morphological maturation of
post-migratory premyelinating oligodendrocytes. The data presented here
demonstrate that FAK can have unique and opposing roles depending on the
maturation stage of the cell and the nature of the prevalent ECM molecule that
the cell encounters. In early stage post-migratory pre-myelinating
oligodendrocytes FAK is involved in restraining morphological maturation in the
presence of fibronectin, while it promotes maturation in the presence of laminin2. Based on the mixed substrate data, it is the restraining role of FAK that
predominates in these early stage cells. In the later stage post-migratory premyelinating oligodendrocytes FAK’s role in restraining morphological maturation
in the presence of fibronectin is significantly diminished or even lost. FAK’s
maturation promoting role, however, still remains active. Taken together, these
data uncover the complexity of FAK’s role in the regulation of morphological
maturation of post-migratory premyelinating oligodendrocytes and they suggest
that proper oligodendrocyte maturation requires a well coordinated balance
between maturation restraining and promoting mechanisms.
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Figure 4.7 siRNA treatment of differentiating oligodendrocytes reduces FAK
protein levels without significantly affecting cell viability. (a-b) Bar graphs
representing FAK protein levels as determined by Western blot analysis for early
(a) or later stage (b) post-migratory premyelinating oligodendrocytes treated with
a siRNA pool against FAK (siFAK) or a non-targeting siRNA pool as control
(siControl) in the presence of fibronectin (Fn) or laminin-2 (Ln). Protein levels
were quantified using enhanced chemiluminescence (ECL) detection in
combination with VersaDoc imaging and the use of the QuantityOne software
package (BioRad Laboratories, Hercules CA). GAPDH protein levels were used
for normalization. A representative Western blot is shown in the inset in (a).
Dashed lines represent control levels of FAK protein, which were set to 100% for
each condition. The efficiency of the siRNA transfection for all conditions was
approximately 70% (data not shown). (c-d) Bar graphs representing the
percentage of enzymatically converted calcein AM-positive (live; black bars) or
ethidium homodimer-positive (dead; grey bars) cells following treatment with a
siRNA pool against FAK (siFAK) or control siRNA pool (siControl) in the
presence of fibronectin (Fn) or laminin-2 (Ln). In (c) the results for early stage
post-migratory premyelinating oligodendrocytes are shown, whereas in (d) the
results for the later stage cells are depicted. In all bar graphs, means and
standard errors of at least three independent experiments (25 cells each per
condition) are shown. Stars indicate an overall two-tailed significance level of
p<0.05 as determined by Student’s t-test analysis.
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Figure 4.7
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Figure 4.8 The protein levels of the non-receptor tyrosine kinase family member
Pyk2 (a and b) and the src kinases Fyn (c and d) and Lyn (e and f) are not
significantly affected upon siRNA-mediated FAK knock-down. Total cell
homogenates were prepared from early (a, c and e) and late stage (b, d and f)
post-migratory premyelinating oligodendrocytes, treated with a siRNA pool
against FAK (siFAK) or control siRNA pool (siControl) and plated on fibronectin
(Fn) or laminin-2 (Ln). Cell lysates were analyzed by Western blot analysis as
described in Figure 4.7 and normalized to GAPDH. Representative Western
blots of the later stage oligodendrocytes plated on laminin-2 are shown in the
insets in (b, d, and f). Dashed lines represent control levels of protein, which
were set to 100% for each condition. Densitometrical measurements were
analyzed for at least three independent experiments (p values are indicated in
white on each bar). g) Both fibronectin and laminin-2 are present in vivo in the
mouse optic nerve at developmental time points when oligodendrocyte
maturation and myelination occur. Whole tissue homogenates were prepared
from postnatal day (P) 2, 5, 14 and 30 optic nerves. Homogenates were analyzed
using Western blots as described in Figure 4.7
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Figure 4.8
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Figure 4.9 Inhibition of FAK’s catalytic activity using the inhibitor PF573228 does
not significantly affect the viability of early and later stage post-migratory premyelinating oligodendrocytes. Bar graphs representing the percentage of
enzymatically converted calcein AM-positive (live; black bars) or ethidium
homodimer-positive (dead; grey bars) cells following treatment with PF573228
(PF288) or vehicle (control) in the presence of fibronectin (Fn) or laminin-2 (Ln).
In all bar graphs, means and standard errors of at least three independent
experiments (25 cells each per condition) are shown. Stars indicate an overall
two-tailed significance level of p<0.05 as determined by Student’s t-test analysis.
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Chapter 5
Final conclusions
Various pathological conditions affect the oligodendrocyte’s myelin sheath
and hence disrupt the ability of axonal signals to be communicated effectively
leading to a multitude of devastating symptoms. As discussed in chapter one the
most prevalent primary demyelinating pathology of the CNS in humans is MS.
While there are premyelinating oligodendrocytes found in at least some MS
lesion, their final maturation appears blocked and there is little to no successful
remyelination (Chang et al. 2002, Kuhlmann et al. 2008). Due to the lack of
remyelination in pathologies involving oligodendrocyte and myelin sheath
destruction, identifying potential targets that will enhance the derelict
endogenous remyelination could lead to potential cures for these pathologies. In
order to fully understand the optimal therapeutic targets that will promote
remyelination in pathologies, such as MS, it is first essential to understand the
factors involved in developmental oligodendrocyte maturation and myelination.
Throughout development oligodendrocytes undergo many drastic
morphological metamorphoses; developing from bipolar OPCs into highly
complex premyelinating oligodendrocytes and finally into fully myelinating mature
oligodendrocytes. Such extreme morphological remodeling requires drastic
cytoskeletal rearrangement. FAK is a known leading regulator of cytoskeletal
rearrangement and hence an ideal candidate for further exploration into its role
during developmental oligodendrocyte morphological maturation.
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In vivo analysis of FAK during initial CNS myelination
In order to ascertain if FAK is involved in later stage oligodendrocyte
morphological maturation and initiation of myelination, temporally-regulated
oligodendrocyte-specific FAK knockout mice were analyzed (Figure 2.1). These
studies demonstrate that during development FAK expression is required for
appropriate initiation of myelination. Mice lacking FAK in oligodendrocytes during
later stages of morphological remodeling and initiation of myelination have fewer
myelinated fibers than control littermates (Figure 2.2). The hypomyelinating
phenotype without FAK expression in oligodendrocytes was also observed by
ffrench-Constant’s group, finding that this phenomenon is primarily restricted to
the small diameter axonal fibers during initiation of myelination in conditional
knockout mice (FAKflox/flox; CNP/Cre) (Camara et al. 2009). This additional
information is of interest since the small diameter axonal fibers are the last to be
myelinated during normal development (Hildebrand & Waxman 1984, Fraher et
al. 1988, Schwab & Schnell 1989).
We further explored the possible explanations for this hypomyelination
and discovered that the reduction in myelinated axonal fibers could be due to
inappropriate morphological remodeling of the oligodendrocyte process network
prior to and during initial myelination. FAK null oligodendrocytes have a reduced
number of primary processes (Figure 2.4). These data could indicate that normal
myelination can progress to a point at which time the resources of the FAK null
oligodendrocyte are depleted and the last fibers to be myelinated, the small
diameter fibers, are left unmyelinated. Alternatively this could involve the relation
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of axonal diameter size to the number of internodal segments myelinated by a
single oligodendrocyte, i.e. that oligodendrocytes that myelinate large diameter
axons myelinate fewer internodal segments than those that myelinate small
diameter fibers (Butt & Ransom 1989, Remahl & Hilderbrand 1990). Due to the
reduction in the number of primary processes the FAK-null oligodendrocytes
could be ideal for myelinating the larger diameter fibers, however, they might not
have the required number of processes to efficiently myelinate the small diameter
axon’s internodal segments.
In both oligodendrocyte-specific FAK-null mouse systems myelin appears
normal in the adults suggesting a transient effect in which the timing of
myelination is negatively affected (Figure 2.5 (Camara et al. 2009)). The normal
myelination seen in the adult FAKflox/flox; CNP/Cre mice could be due to early
knock-out of FAK under the CNP promoter. The early elimination of FAK from
oligodendrocytes could allow for the upregulation of a compensatory mechanism
that could repair the initial hypomyelination observed leading to the transient
phenotype. One of the main candidates for such a compensatory mechanism is
Pyk2 since it is highly expressed in the brain as well as being expressed in
oligodendrocytes (Figure 4.8) and is the only other family member of the nonreceptor tyrosine kinase family (Menegon et al. 1999). Pyk2, however, has been
shown incapable of replacing all of the functions FAK fulfills, including those
involved in cytoskeletal dynamic regulation (Schlaepfer et al. 1999, Klingbeil et
al. 2001). The levels of Pyk2 are also shown to be upregulated in MS lesions
weakening the idea that Pyk2 could effectively compensate for FAK and promote
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normal myelination since it is highly expressed during a pathological condition in
which remyelination is limited (Comabella & Martin 2007).
A more likely candidate involved in a possible compensatory mechanism
would be ILK, which is associated with focal adhesion molecules and is
expressed in the CNS (Chun et al. 2003, Wu & Dedhar 2001). ILK has also been
shown to be involved in myelin sheet formation in vitro; dominant negative ILK
reduces the formation of myelin sheets on the permissive laminin-2 ECM
substrate (Chun et al. 2003). Therefore ILK could signal to many of the
molecules also regulated by FAK and could compensate for FAK function in
myelin formation providing that it is activated at an early enough time point.
Our system also displays proper myelination in the adult, an effect that
could possibly be due to the timing of induced FAK knock-out rather than
reflecting a transient effect. To remain consistent with the developmental
studies, tamoxifen injections, and thus induction of FAK knock-out, were carried
out from P2 through P14 allowing tamoxifen to be flushed from the system
around P16-17, a time point at which myelination is still highly active in the optic
nerve. Without tamoxifen in the system Cre recombinase is unable to
translocate to the nucleus effectively inhibiting FAK knockout in oligodendrocytes
derived following tamoxifen elimination. A second wave of oligodendrocytes,
expressing normal levels of FAK, could have migrated to the areas of
hypomyelination and myelinated any of the small diameter fibers that the FAK
null oligodendrocytes were unable to myelinate, effectively repairing the
hypomyelinating phenotype (Colello et al. 1994, Kessaris et al. 2006).
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Currently the exact nature of possible compensatory mechanisms is
unknown. The most elegant way to asses the actual role of FAK throughout
development, from oligodendrocyte morphological maturation through myelin
maintenance, would be to continue tamoxifen injections in our inducible FAK null
mice throughout adulthood, thus eliminating the possibility of any unaffected
oligodendrocytes repairing the hypomyelinated region. Additional studies in
which the timing of tamoxifen injection is altered to target the development of
oligodendrocytes in other CNS regions could also determine whether the effect of
FAK on oligodendrocyte initial myelination is ubiquitous throughout the CNS or is
region specific.

In vitro analysis of FAK in post-migratory premyelinating oligodendrocyte
morphological maturation
Since we discovered that inappropriate oligodendrocyte morphological
remodeling could be responsible for the hypomyelination observed during initial
myelination in vivo we began exploring the possibility that FAK could be involved
in oligodendrocyte morphological maturation leading up to myelination. To
further elucidate FAK’s role during oligodendrocyte morphological remodeling
prior to myelination we utilized an in vitro system which allowed for strict
regulation of both the environment and developmental stage of the
oligodendrocytes analyzed.
These studies revealed that FAK can regulate morphological maturation of
post-migratory premyelinating oligodendrocytes in a unique and opposing fashion
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that is dependent on the nature of the ECM substrate present and that is, for the
most part, mediated by FAK’s autophosphorylation and catalytic activity. Early
post-migratory premyelinating oligodendrocytes with a reduction in appropriate
FAK signaling (either via a siRNA knockdown of FAK protein levels or an
inhibition of FAK catalytic function) in the presence of fibronectin have unbridled
process networks, whereas when in the presence of laminin-2 oligodendrocytes
with reduced FAK signaling are unable to form or maintain the appropriately
substantial morphology required at that stage of development (Figure 4.2 and
Figure 4.5). Both signaling pathways in the presence of fibronectin and in the
presence of laminin-2 converge on FAK and, based on the ECM signal that FAK
receives, it is able to uniquely modulate the oligodendrocyte process network.
In the proposed mechanism fibronectin most likely signaling through the
αvβ3 integrin receptor, would signal for morphological remodeling at early
developmental time points (Olsen & ffrench-Constant 2005, Lee et al. 2006).
This association is thought to lead to recruitment of FAK and the SFK member,
Lyn, to the focal adhesion. Lyn is the most likely candidate for this association
since it is upregulated at an early time point during oligodendrocyte development
and has been shown to be associated with the αvβ3 integrin receptor (Colognato
et al. 2004, Kramer et al. 1999).
The restriction of the oligodendrocyte process network in the presence of
fibronectin could be associated with FAK signaling to cytoskeletal regulators.
This signaling pathway could involve signaling to Rho family GTPases such as
RhoA, Rac, and Cdc24, which have been well characterized to modulate the
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cytoskeleton in various cell types and specifically during oligodendrocyte
development, as discussed in chapter one (Sypecka et al. 2009, Mitra et al.
2005, Romer et al. 2006, Hoshina et al. 2007, Rico et al. 2004, Moeller et al.
2006, Wang et al. 2009). FAK associates with both GEFs, which promote
activation of GTPases, and GAPs, which decrease the activity of GTPases,
allowing for tightly regulated mediation of process morphology (Tomar &
Schlaepfer 2009). A limited activation of p190RhoGAP and/or GRAF by FAK
would enhance RhoA activity, previously demonstrated to mediate cytoskeleton
contraction and process retraction, which could lead to reduced process network
formation in the early oligodendrocytes (Liang et al. 2004, Taylor et al. 1998).
The decrease in FAK association with p130Cas could also lead to restricted Rac
activation which would reduce process outgrowth limiting the ability of an early
oligodendrocyte to efficiently differentiate morphologically (Mitra et al. 2005,
Liang et al. 2004, Schlomann et al. 2009).
Inappropriate membrane transport, which is observed in oligodendrocytes
in the presence of fibronectin, could keep proteins from being over produced and
transported, which would reduce process network expansion, thus reducing the
risk of over utilizing and depleting resources required for later stages of
morphological maturation and myelination (Siskova et al. 2006).
The FAK-mediated effect on oligodendrocyte morphology in the presence
of fibronectin was also found to be, at least in part, developmentally regulated.
Later stage post-migratory premyelinating oligodendrocytes no longer respond to
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the FAK-mediated restriction of the process network in the presence of
fibronectin (Figure 4.3 and Figure 4.5).
Interestingly fibronectin levels are upregulated and incongruous fibronectin
deposits are found throughout MS lesions (Comabella & Martin 2007, Sobel
1998). The remodeling of fibronectin as well as other ECM molecules is also
skewed in MS lesions (Cossins et al. 1997, Sobel 1998). In concert with the
above proposed mechanism of early oligodendrocyte morphological remodeling,
the fibronectin deposits within the MS lesion could prevent efficient maturation of
differentiating oligodendrocytes and thus restrict remyelination.
The association of oligodendrocytes with laminin-2 is most likely mediated
through the α6β1 integrin. As discussed in chapter three, laminin-2 is a well
characterized regulator of oligodendrocyte morphological remodeling and the
α6β1 integrin receptor has been implicated in regulating oligodendrocyte
maturation and myelination (Baron et al. 2005, Colognato et al. 2007, Olsen &
ffrench-Constant 2005, Chun et al. 2003, Colognato et al. 2002). This
association recruits FAK and the SFK member, Fyn, which in turn signals FAK to
perform various cellular functions. Fyn has been greatly implicated in the
morphological differentiation regulated by laminin-2 signaling and is highly
associated with α6β1 integrin (Colognato et al. 2004, Osterhout et al. 1999,
Antonyak & Cerione 2009).
Due to the observation that neither Fyn nor Lyn levels change in our
system (Figure 4.8c-f) it is unlikely that there is a feedback loop affecting the
expression of SFKs, or if there is a feedback loop the small percentage of SFK
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found in association with FAK (only 3-5%) is not substantial enough to show an
overall change (Cobb et al. 1994).
A strong candidate for a downstream signaling target of FAK involved in
the morphological maturation of oligodendrocytes in the presence of laminin-2 is
anti-apoptotic serine threonine kinase (Akt) via activation of PI3K. FAK has been
shown to activate PI3K which could then activate Akt signaling for various cellular
functions (Chen & Guan 1994, Del Re et al. 2008).
The requirement of Akt activity for oligodendrocyte survival has been well
characterized in vitro (Cui et al. 2005, Bibollet-Bahena & Almazan 2009). More
importantly, the activation of the PI3K/Akt signaling pathway has also been
associated with cytoskeletal rearrangement and morphological remodeling (Del
Re et al. 2008, Endo & Yamashita 2009). PI3K-induced Akt activation is
enhanced with the progression of oligodendrocyte differentiation (Tyler et al.
2009). Activation of the PI3K/Akt signaling pathway enhances CNS myelination
while inhibition of this pathway has been shown to reduce the efficiency of
myelination (Flores et al. 2008, Barros et al. 2009, Fraser et al. 2008, Tohda et
al. 2006). Therefore it is possible that upon association of laminin-2 with α6β1
integrin Fyn enhances FAK-mediated activation of PI3K which could lead to
increased activation of Akt and oligodendrocyte differentiation and the expanded
process network observed.
The data presented in this dissertation reveal the importance of FAK
signaling during oligodendrocyte morphological maturation and myelination in
CNS development. Due to the opposing roles of FAK in the presence of the
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different ECM molecules, fibronectin or laminin-2, meaningful direct regulation of
FAK in pathological conditions may be difficult to achieve. A potential approach
to indirectly modulate FAK-mediated oligodendrocyte morphological maturation
during pathology would be to manipulate the ECM environment or activation of
FAK-associated molecules, primarily Fyn and Lyn or integrin receptors. Thus,
the findings presented here highlight the importance of better understanding the
molecular mechanisms regulating developmental myelination in order to develop
novel therapies which would promote remyelination in MS and other
oligodendrocyte pathologies.
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↑ RhoA
↓ Rac
↓ Cdc42

FAK

↑ Akt
↑ PI3K
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FAK
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α6β1
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Figure 6.1 Theoretical schematic for FAK-mediated signaling pathways
regulating morphological maturation of post-migratory premyelinating
oligodendrocytes. Upon association of fibronectin with the integrin receptor αvβ3
a complex of FAK and Lyn is activated. This activation could lead to the
regulation of the Rho family of GTPases, primarily RhoA, Rac, and Cdc42,
enhancing oligodendrocyte process retraction and restricting oligodendrocyte
process extension thus holding the early stage post-migratory premyelinating
oligodendrocyte in a less mature morphology. Upon association of laminin-2 with
the integrin receptor α6β1, however, activation of a FAK-Fyn complex initiates
activation of the PI3K/Akt pathway leading to enhanced oligodendrocyte
morphological maturation and myelination.
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